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Abstract  
Background: There is variation in response to CBT for anxiety and depression that is not 
fully understood. Some mental health disorders are associated with executive functioning 
(EF) deficits. These EF deficits potentially have an important role in clients engaging with 
CBT, applying the principles and responding to it as an intervention. This systematic 
review explores whether EF is a predictor for CBT response. 
Method: CINAHL, Cochrane Library, Embase, PsychINFO and Psychology and 
Behavioural Sciences Collection were systematically searched for studies published up to 
June 2018 that measured whether EF scores were related to post-CBT intervention 
symptom measures for adults. Risk of bias was measured by the Effective Public Health 
Practice Project (EPHPP) quality rating tool.  
Results: Eleven studies met the inclusion criteria. Quality ratings ranged: five studies were 
found to be of moderate quality, four were ‘weak’ and two ‘strong’. Two out of four papers 
that focused on OCD, and one GAD focused paper, found that a lower EF score at baseline 
predicted poorer CBT response. There was no support that EF predicted CBT outcome for 
depression.  
Conclusion: Future research could: measure whether those with non-improved EF 
following CBT for anxiety predicts CBT response; examine whether there is a particular 
‘cut-off’ of EF score that indicates a better CBT response, suggesting a threshold effect 
rather than linear; and creating composite EF scores for the aspects of EF rather than one 
composite score or a number of separate scores.  
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Executive Functioning, CBT, Predictors of treatment response 
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1. Introduction  
Cognitive Behavioural Therapy (CBT) is the first line psychological treatment for anxiety 
and depression disorders, according to NICE guidelines and the Matrix (NES, 2015). A 
number of systematic reviews contribute to this evidence by comparing the efficacy of 
CBT to treatment as usual, medication and other therapeutic modalities for depression and 
anxiety (Hofmann & Smits, 2008; Hofmann, Asnaani, Vonk, Sawyer & Fang, 2012). Due 
to variation between studies about CBT's effectiveness, the predictors and moderators of 
CBT outcomes have been examined to determine for whom CBT is most effective. 
 
Previous studies indicate that patients with depression (Hammar & Årdal, 2009) and 
anxiety disorders (Bar-Haim et al., 2007), particularly OCD (Shin, Lee, Kim & Kwon, 
2014), have impaired EF.  EF incorporates a diverse range of cognitive abilities that 
control other cognitive processes including, “planning, working memory, attention, 
inhibition, self-monitoring, self-regulation, and initiation” (Goldstein & Naglieri, 2014, 
p3). Lezak and colleagues describe EF as being responsible for how and whether people do 
a task or goal directed activity and includes “the highest level of human functioning, such 
as intellect, thought, self-control, and social interaction” (2012, p42). Diamond (2013) 
argues there is general agreement for three core processes of EF: inhibition and 
interference control, working memory and cognitive flexibility. From these core processes 
arise “higher-order EFs”, for example reasoning, problem solving and planning. A 
challenge within the literature are the broad descriptions of EF processes and lack of 
unified definition due to its complexity. 
 
In context of mental health, these impairments may present as rumination or apathy for 
depression (indicating difficulty in task switching or initiation), acting on obsessions and 
finding it difficult to stop in OCD (indicating a difficulty with inhibiting and task 
switching), and difficulties in ignoring irrelevant information and having a number of 
concurrent worries in GAD (indicating a difficulty in organising information and anxieties 
affecting working memory). It is currently unclear whether EF deficits are causal of mental 
health difficulties, or whether there is a correlation between the two (Moritz et al., 2002; 
Watkins & Brown, 2002). These EF deficits potentially have an important role in clients 
engaging with psychological therapy, applying the principles and responding to it as an 
intervention. 
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CBT involves a behavioural component requiring clients to set and work towards goals. It 
also involves problem solving skills and abstract thought to work with cognitions and 
create more psychological flexibility to allow clients to adapt to situations. The latter has 
been suggested to be prominent in understanding and improving psychological health 
(Kashdan & Rottenberg, 2010). This is important because if EF prevents CBT recipients 
from being able to engage and improve their psychological health, knowledge of this can 
help clinicians consider whether CBT is the most appropriate intervention and adapt to 
compensate for this deficit and optimise response.  
 
Meta-analyses have reviewed the relationship between EF and pharmacological treatment 
for depression (Pimontel, Culang-Reinlieb, Morimoto & Sneed, 2012; McLennan & 
Mathias, 2010; Tunvirachaisakul et al., 2018). Findings were mixed but indicated that a 
higher score in some EF domains, such as planning, organisation and verbal fluency, had 
an association with a poorer anti-depressant response. To date there are no published 
systematic reviews specifically examining the role of EF on symptom reduction following 
CBT. This systematic review will consider this within anxiety and depression disorders to 
explore and clarify whether EF is a potential predictor for CBT response. Due to the 
inconsistencies of findings in other systematic reviews, the type of executive test, and what 
part of EF it measures, will be described.  
 
2. Research Questions 
i.  Does executive functioning affect CBT outcomes in adults with anxiety or mood 
disorders? 
ii.  If EF affects CBT outcomes, what specific aspects/sub-elements are relevant to 
test?  
 
3. Method  
3.1  Search Strategy 
This review followed PRISMA reporting standards. (Moher, Liberati, Tetzlaff , Altman & 
Prisma Group, 2009). Online bibliographic databases (CINAHL, Cochrane Library, 
Embase, PsychINFO and Psychology and Behavioural Sciences Collection- all years) were 
searched on 16th November 2017. Two key academic journals, Journal of Clinical and 
Consulting Psychology and Behavioural Research and Therapy, were manually searched 
in addition to references of the studies included in this review. The following terms were 
used to search the databases (see Appendix 1.2 for full search strategy): (executive 
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function* or dysexecutive function* or executive skills or neuropsych* predictors or 
executive deficits or predictors of treatment response) AND (cbt or cognitive behavio* or 
Third wave or 3rd wave or (acceptance n2 commitment therapy) or cognitive therapy or 
behavio?ral activation or cognitive behavio?ral analysis system of psychotherapy or 
dialectical behavio* therapy or meta cognitive therapy or metacognitive therapy or 
mindfulness based cognitive therapy or schema therapy or functional analytic 
psychotherapy or integrative behavio?r couple therapy or compassion focussed therapy or 
compassionate mind training or motivational interviewing).   
 
3.2   Eligibility Criteria 
Studies were included if they met the following criteria:  
1. Clinical trial  
2. Published in peer reviewed journal. 
3. Participants aged 18 or over in inpatient and outpatient settings. 
4. Participants had a DSM-IV or DSM-V anxiety or mood disorder.  
5. CBT was one of the intervention conditions. 
6. Specific EF tests were administered pre-intervention. 
7. Reported statistical significant data on the influence of EF measures on primary 
diagnosis treatment response to CBT outcome.  
8. Outcome measures used that aimed to measure symptoms of the participants’ 
primary diagnosis. 
9. In English language. 
 
3.3  Data Extraction   
A structured data extraction form (see Appendix 1.3) was used to collect data on a range of 
research and clinical characteristics. 
 
To answer the research questions, the papers will be described and then analysed using 
narrative synthesis. As the statistical analysis, EF tests, and outcome measures varied 
between studies, a meta-analysis was not performed.  
 
3.4  Quality Assessment 
Risk of bias was evaluated using the Effective Public Health Practice Project Quality 
Assessment Tool (EPHPP) (Thomas, Ciliska, Dobbins & Micucci, 2004). The EPHPP is 
comprised of six components, scored as ‘strong’, ‘moderate’, or ‘weak’. These feed into a 
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global rating of ‘strong’ (no components ‘weak’), ‘moderate’ (one component ‘weak’) or 
‘weak’ (two or more components ‘weak’). It has good construct and content validity with a 
test-retest reliability Kappa statistic of 0.74 (Thomas et al., 2004) and excellent final grade 
inter-rater agreement in comparison to the Cochrane Collaboration Risk of Bias Tool 
(Armijo-Olivo, Stiles, Hagan, Biondo & Cummings, 2012). The author, and an 
independent rater, rated all papers independently before comparing scores. The EPHPP’s 
dictionary was used by both raters to maximise interrater reliability.   
 
4. Results  
4.1 Study Selection 
The search strategy, conducted in November 2017, yielded 2232 papers following the 
exclusion of duplicates. The manual search of academic journals yielded no additional 
papers that were not found in the original search. The remaining 2232 were screened 
against the inclusion criteria via their title and abstract. This led to a further 2194 articles 
being excluded, leaving 38 articles for full review. Following full review, 28 articles were 
excluded. For thoroughness, these searches were re-run in June 2018 to include papers 
published between 2017-2018: one additional paper was identified and added so the final 
review set comprised 11 papers. Figure 1 illustrates the study selection process. 
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Figure 1. PRISMA Flow Diagram (Moher et al., 2009). 
 
4.2. Descriptive Data 
Table 1 reports key methodological descriptive features and summary of results from the 
studies. 
4.2.1 Studies and Population 
Six of the studies were conducted in the USA and in total 565 participants were included in 
the 11 studies’ CBT intervention group pre-attrition. Mean ages ranged from 29.56-69.94. 
Years of publication ranged from 2003-2018. Seven of the studies (see Table 1) were 
secondary papers related to main clinical trial outcome papers. Consequently, the main 
papers’ methodology sections were consulted when describing these papers, and when 
using the EPHPP. Quality ratings ranged: five studies were found to be of moderate 
quality; four were ‘weak’, and two ‘strong’.   
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Intervention not CBT 
(n= 10) 
 
Study does not aim to predict 
outcome 
(n= 6) 
 
Systematic Review, thesis or 
conference paper 
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Not published in English speaking 
journal 
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(n= 2) 
Primary diagnosis not within 
Anxiety or Depression disorders in 
DSM-V 
(n= 2) 
 
 
 
Studies included in 
systematic review 
(n= 11) 
Additional article 
identified in June 2018 
(n= 1) 
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 Table 1. Summary of Methodology, Results and Quality Ratings 
Author/ 
Year 
[main 
trial 
paper] 
Where Inclusion/Exclusion Criteria  
(see Appendix 1.4 for full) 
Age        M 
(SD) CBT 
group 
Attrition Comparison 
Groups (n) 
CBT 
Type 
Design 
Study 
Quality 
Rating 
Comparison 
Outcome 
Measures 
Summary of Key Results 
Braga et 
al. (2016) 
BRA + 18-65 Years 
+ Primary diagnosis of OCD (SCID-I) 
 
- Lifetime diagnosis of neurological 
disorders 
- Psychosis, ASD, ID 
43.4 (14.0) 31% CBT (75) vs. 
WL (75) 
12 Group 
Sessions 
Non-
controlled 
RCT 
Weak Y-BOCS -  YBOC-R (>35% reduction in YBOCS) performed 
better in Trails (B-A) p = .011 
-  Weak but partial association Trails (B-A)- responsible 
for 17.5% of Y-BOCS variation score β = 0.211 
-  No other significant differences 
Carter et 
al. (2018)* 
[Carter et 
al., 2013] 
NZ + 18 years and over 
+ MDD (SCID) 
+ Free of centrally acting drug other than 
hypnotic and contraception  
 
- Schizophrenia or bipolar diagnosis 
- Major medical condition 
- Failure to respond to trial of CBT/ST in 
the past year 
38.2  (11.2)  
50% CBT (50) vs. 
ST (50) 
Weekly 
individual 
sessions 
for 6 
months, 
monthly 
boosters 
for 6 
months 
RCT Moderate MADRS - Non-significant: r = -0.24 p<0.1 
D’Alcante 
et al. 
(2012)* 
[Belotto-
Silva et 
al., 2012] 
BRA + 18-65 Years 
+ Primary Diagnosis of OCD (SCID-I) 
- Prior exposure to psychotropic medication 
or CBT 
- General medical condition 
- Severe mental illness other than OCD 
32.7 (9.7) 24% CBT (18) vs. 
DT (20) 
12 Group 
Sessions, 
3 follow 
up 
Practical 
Clinical 
Trial 
Moderate Y-BOCS 
 
-  Shorter time to completion of part D of Stroop 
predictive of better response p = 0.001 
-  Longer time to complete Words in Stroop 
predictive of better response p = 0.025 
-  Fewer errors in Colour/Word in Stroop showed a 
better treatment response p = 0.001  
Deckersba
ch et al. 
(2018) 
USA + 18-65 Years 
+ Diagnosis of Bipolar I (MINI) 
+ Current MDD 
+ Stable Pharmacology  
 
- Previous CBT treatment 
- Rapid cycling or current mixed episode 
Bipolar Disorder subtype 
- Serious medical conditions 
- Neurological disorder  
- Lifetime schizophrenia spectrum disorder 
38.76 (13.8) 25% CBT (17) vs. 
SP (15) 
18 
Sessions 
Individual, 
3 Boosters 
Pilot RCT Moderate HDRS 
 
- No significant correlations with HDRS: 
   - Trails switching: r= -0.22, p=0.31; 
   - Colour/word interference r=-0.32 p=0.13 
   - Colour/word switching r=-0.30 p=0.15 
   - Free sorting r=-0.19 p=0.40 
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Dobkin et 
al. (2012)* 
[Dobkin 
et al., 
2011] 
USA + Diagnosis of Major Depression, 
Dysthymia or Depression NOS (SCID-I) 
+ Diagnosis of Parkinson’s Disease 
+ Ages 35-85 
+ Stable Medication 
+ Family Friend or Carer participate 
- Receiving CBT elsewhere 
- Dementia, Bipolar, Psychotic Spectrum, or 
Substance Abuse Disorders  
- Unstable medical condition 
63.73 (9.89) 10% CBT (41) vs. 
Clinical 
Monitoring 
(39) 
10 
Sessions 
Individual 
4 
caregiver 
sessions 
RCT Strong HDRS 
BDI 
 
- No significant moderator  
-  EF related to CBT short term maintenance of 
treatment gains: Week 14 A Priori Model with BDI 
and Trails (B-A) β=0.26, p=0.011. 
 
Goodkind 
et al. 
(2016)*  
[Thompso
n et al., 
2005] 
USA + 60+ years+ Primary diagnosis of major 
depression or dysthymia on MINI 
 
- Active suicidality, psychosis, 
substance/alcohol abuse 
- Manic episode in last year 
- <25 on MMSE 
69.4 (7.1) 35% (156 
recruited) 
CBT (55) 12 
Sessions 
Individual 
Clinical 
Cohort 
Study 
Weak BDI-II -  Worse performance on WCST predicted better 
CBT response 
    β = -0.40,  t=-2.64 p=0.01 
-  Verbal Fluency (β=0.07 t=0.48 p>0.05) and Stroop 
(β=0.04, t=-0.27 p>0.05) not significant predictor  
Julian & 
Mohr 
(2006)*  
[Mohr et 
al., 2001] 
USA + Diagnosis of MS: relapsing-remitting or 
secondary progressive disease course 
+ Diagnosis of current MDD (SCID-I) 
+ No concurrent treatment  
 
- DSM-IV Axis I psychiatric disorder other 
than MDD or GAD 
- <5th percentile on 3/6 cognitive domains 
- Current MS exacerbation 
- Head Injury or neurological disorder other 
than MS 
- Concurrent treatment for depression 
44.08 (9.67) 
(all 
participants -  
CBT-group 
ages not 
reported) 
15% CBT (20) vs. 
Sertraline (15) 
vs. Supportive 
Expressive 
Group 
Therapy (24) 
16 
Sessions 
Individual 
RCT Strong HDRS -  No significant predictors 
-  Stroop condition p = 0.72, f = 0.14, r2 = 0.03 (with 
alpha .01), β = 0.09 
-  Verbal Fluency p = 0.26, f = 1.35, r2 = 0.10 (with 
alpha .07) β = 0.27 
Mohlman 
& 
Gorman 
(2005)* 
[unreport
ed] 
USA + 60+ years 
+ Diagnosis of GAD (SCID) 
+ Read and write in English 
 
- Suicidality last 6 months 
- Concurrent treatment 
- Never experienced psychotic symptoms  
68.75 (5.61) 19% CBT Intact EF 
(10) vs. CBT 
Dysexecutive 
functioning 
(12) vs. Wait 
List Control 
Group (10)  
13 
Sessions 
Individual 
6 Monthly 
Booster 
Sessios 
Pilot RCT Moderate BDI 
BAI 
STAI-trait 
PSWQ 
SCL 
-  Split participants into 3 groups: intact EF; EDF; 
Improved EF, along with WL. 
-  Improved EF group significantly greater decrease 
than EDF and WL on STAI-trait.  
-  No statistics relating to this reported. 
Mohlman 
(2013) 
USA + 60+ years 
+ Diagnosis of GAD (SCID) 
+ +24 on MMSE 
+ Average or better range in BNT 
 
- No anxiety medication 
69.94 (6.68) 16% GAD CBT 
(69) vs. 
Control Group 
(52)  
8 Sessions 
Individual 
Outpatient 
Clinical 
Cohort 
Study 
Weak PSWQ 
BDI 
GAD-Q 
-  Compare within and between group performance on 
Nonverbal Executive Skills Tests and Verbal 
Executive Skills Tests.  
-  No significant result found.  
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Moritz et 
al. (2005) 
DEU + OCD Diagnosis using neuropsychiatric 
interview 
+ 18+ 
- Somatic or psychopathological syndromes 
R: 32.59 
(9.55) 
NR: 35.48 
(10.79) 
12% CBT (156) 8 sessions 
Individual 
and 
Group, 
Inpatient 
and 
Outpatient 
Clinical 
Cohort 
Study 
Weak Y-BOCS 
HDRS 
-  No significant results of EF scores between R (>35% 
reduction in YBOCS) and NR: Verbal Fluency d = -
.08; WCST (perseveration d = .28; WCST Categories 
d = .13; DAT Errors d = .61; Digit Span Backwards d 
= .06, Trails B d = .12 
-  No neuropsychological tests correlate with differences 
in YBOCS score or HDRS r < .30 
Vandborg 
et al. 
(2016)* 
[Vandbor
g et al., 
2014] 
DNK + OCD Diagnosis (DSM-IV) 
+ 18-60 Years 
+ Danish native language 
+ 16+ Y-BOCS 
- HDRS > 17 
- Pharmalogical treatment other than SRIs 
- Onset of treatment with SRIs less than 3 
months before onset of CBT 
Recovered: 
29.56 (8.85) 
Non-
recovered: 
30.74 (7.74) 
7% CBT (42) Mean of 
12.44 
sessions 
Group 
(25) and 
Individual 
(14) 
Clinical 
Cohort 
Study 
Moderate Y-BOCS 
HDRS 
- None of baseline neuropsychological test variables 
predicted change in OCD symptoms after CBT 
- No statistics relating to this reported. 
* denotes study that is a secondary paper to a larger trial 
Abbreviations: ASD, Autism Spectrum Disorder; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; CBT, Cognitive Behavioural Therapy; DSM, Diagnostic and Statistical Manual of Mental Disorders; DT, Drug 
Treatment; EDF, Executive Dysfunction; LIFE-RIFT, Range of Impaired Functioning Tool; GAD, Generalised Anxiety Disorder; GAD-Q, Generalised Anxiety Disorder Questionnaire; HDRS, Hamilton Depression Rating Scale; ID, 
Intellectual Disability; MADRS, Montgomery-Asberg Depression Rating Scale; MDD, Major Depressive Disorder; MINI, Mini-International Neuropsychiatric Interview; MMSE, Mini-Mental State Examination; MS, Multiple Sclerosis; 
NOS, Not otherwise specified; OCD, Obsessive Compulsive Disorder; PSWQ, Penn State Worry Questionnaire; RCT, Randomised Control Trial; R, Responder; NR, Non-Responder; SCID, Structured Clinical Interview for DSM; SCL, 
Symptom Checklist; SP, Supportive Psychotherapy; SRI, Serotonin Reuptake Inhibitor; ST, Schema Therapy; STAI-Trait, State-Trait Anxiety Inventory; TBI, Traumatic Brain Injury; WCST, Wisconsin Card Sorting Test; WL; Waiting 
List; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.
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4.2.2. Quality Ratings 
Using the EPHPP, it was found nine papers had complete global rating inter-rater 
agreement. Two papers did not meet agreement (Mohlman & Gorman, 2005; Vandborg, 
2016). Disagreement in rating was agreed through discussion with both being rated as 
‘moderate’ rather than ‘weak’. The two studies that were rated as ‘strong’ (Dobkin et al., 
2012; Julian & Mohr, 2006) were clinical trials that provided the most detailed description 
(within their main trial paper) of their selection bias and blinding methods. The four 
studies that were rated as ‘weak’ had limited information these aspects (see Appendix 1.5 
for full ratings). 
4.2.3. Diagnosis and Outcome Measures 
Target diagnosis for symptom reduction were either anxiety or depression disorders: four 
studies targeted OCD; five targeted depression, and two targeted GAD. Table 2 shows the 
five most used outcome measures and their mean severity of anxiety and/or depression 
according to the CBT group’s pre-outcome measures’ scores.  
Table 2. Qualitative Descriptors of Mean score for CBT group’s pre-treatment symptom outcome 
measures 
 Y-BOCS 
(Total) 
HDRS BDI PSWQ MADRS  
What it measures OCD Depression Depression Pathological 
Worry 
Depression 
Description of measure 10-items  
Self-Report 
17-items 
Clinician 
Rated 
21-items 
Self-
Report 
16-items 
Self-Report 
10-items 
Clinician 
Rated 
Braga et al. 
(2016) 
 
Severe 
    
D’Alcante et al.  
(2012)  
               
Severe 
    
Moritz et al. 
(2005) 
             
Severe  
              
Mild 
   
Vandborg et al.  
(2016) 
             
Severe 
          
Mild 
   
Deckersbach et al.  
(2018) 
              
Severe 
   
Julian & Mohr  
(2006)  
  
Severe 
   
Dobkin et al. 
(2012) 
  
Severe 
 
Mild 
  
Goodkind et al.  
(2016)  
              
Moderate 
  
Mohlman 
(2013) 
             
 Mild 
               
Moderate 
 
Mohlman & Gorman  
(2005) 
     
High Worry 
 
Carter et al.  
(2018)  
     
Moderate 
 
In eight of the studies, participants fell within the highest severity of their primary outcome 
measure indicating comparable severity of symptoms. Due to the differences in primary 
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diagnosis, there was some variation in outcome measure. However, the HDRS and 
MADRS are positively correlated with the BDI, with respective correlation scores of 
r=0.71 (Beck, Steer & Brown, 1996) and r=0.68-0.75 (Wang & Gorenstein, 2013). This 
suggests the depression scales’ descriptors are comparable.  
4.2.4. Description of Executive Functioning Tests used 
The number and type of EF tests used across the papers varied and are summarised in 
Table 3 alongside a key of what aspect of EF each test was described to have measured. 
Results reported in the studies are presented in Table 1. Authors were contacted when data 
was not reported due to non-significance. Unfortunately, due to inconsistency across the 
papers in how, or whether, the scores were reported, their baseline scores cannot be 
compared (see Appendix 1.6 for summary of available results).  
 
In terms of EF tests, nine out of 11 of the papers used the Stroop test, which measures 
inhibition (colour/word trial) and switching (colour/word switching trial). The next two 
most common tests were card sorting test (six studies); measuring set switching and 
perseveration and Trails (five studies) measuring task switching.  
 
Three papers created composite EF scores. Mohlman (2013) created a composite verbal EF 
score (COWAT; VPA Total; Stroop colour/word; Digit-Span Backwards) and non-verbal 
EF score (Trails B; Matrix Logic; Digit Symbol). Carter et al (2018) did this using four EF 
sub-tests (COWAT; Digit-Span; two CANTAB subtests). Mohlman and Gorman (2005) 
did this using WCST, Matrix Logic and Stroop Interference). These authors gave a 
composite score reported as a standardised z or t score, which was easier to interpret 
compared to raw scores.   
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Table 3. EF Measures Used and Aspect of EF they measure 
*According to descriptions in the papers **Created composite scores from tests  
Abbreviations: AR, Abstract Thinking; CANTAB, Cambridge Neuropsychological Test Automated Battery; CF, Concept Formation; DAT, Delayed Alternation Task; DM, Decision Making; Inh, Inhibition; LNS, Letter Number 
Sequencing; IGT, Iowa Gambling Task; MF, Mental Flexibility; ns, not specified; OAT, Object Alternation Task; Pl, Planning; PS, Problem Solving; RA, Rule Attainment; SA, Selective Attention; ToL, Tower of London task; VF, Verbal 
Fluency; VPA, Verbal Paired Association; WM, Working Memory.
Test Aspect of 
EF 
Tested* 
Braga et al  
(2016) 
Carter et 
al., (2018)** 
D’Alcante et 
al (2012) 
Deckersbac
h et al 
(2018) 
Dobkin et 
al  
(2012) 
Goodkind et al 
(2016) 
Julian & 
Mohr (2006) 
Mohlman & 
Gorman (2005) 
Mohlman  
(2013)** 
Moritz et al  
(2005) 
Vandborg 
et al (2016) 
Total 
out of 
11 
Stroop Inh, MF, 
SA 
                     
 
                 8 
Trails MF                                             6 
VF VF          
 
  
 
          6 
Card Sorting  CF, PS, 
AR, MF 
                 
 
      
 
              6 
Digit-Span WM               6 
Brixton RA            2 
Matrix Reasoning AR, CF            2 
OAT; Hayling;, 
IGT 
MF; Inh; 
DM 
           1 
DAT WM            1 
ToL Pl            1 
LNS WM            1 
VPA; Digit 
Symbol 
ns; MF            1 
CANTAB (Spatial) WM            1 
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4.3. Synthesis of Results: Effect of EF on CBT Outcomes 
Four of the 11 papers reported statistically significant results. Goodkind and colleagues 
(2016) reported that a worse performance on the WCST predicted a better CBT response. 
Braga and colleagues (2016) found those in the responders group performed better in 
Trails (B-A), which suggested it could predict whether individuals respond to CBT in 
terms of Y-BOCS score. D'Alcante (2012) found that participants with OCD who 
committed fewer errors on the colour/word subtest in the Stroop test were significantly 
more likely to respond better to CBT as measured by the Y-BOCS score.  
 
These mixed results made it difficult to draw generalised conclusions. In terms of OCD, 
D’Alcante et al’s (2012) significant results were not found by two of the other three OCD 
studies, with similar patient demographics (e.g. age and initial Y-BOCS scores), that used 
a Stroop test. One of those papers (Braga et al., 2016) was rated as poor quality, 
particularly due to dropout rate, whereas the other two were moderate. However, as 
D’Alcante’s CBT participant number was low (n=17), it was difficult to give more weight 
to their result. Braga et al. (2016) did not find a significant result relating to Stroop but 
reported their ‘responders’ group performed better in Trails (B-A), which suggested task 
switching abilities predicted CBT response; however, none of the other five papers that 
used Trails found a significant result. In addition, this paper’s low-quality rating–  due to 
blindness, sample type and drop-out– indicated these results may not be generalised. 
Neither of the papers rated as ‘strong’ found that EF predicted CBT outcome in depression, 
which indicated that the evidence base is not strong enough to suggest a generalisable 
effect.  
 
The quality of the studies, as measured by the EPHPP, was variable. Four studies were 
considered ‘weak’. This lower rating was mostly due to selection bias (method of 
recruitment, or in particular not reporting the percentage of participation) and blinding, as 
it was not always stated whether it was single or double blinded. It is beneficial to report in 
more detail on both these components due to potential bias not been considered, such as 
whether the participants are representative or if they, or the researcher, are influenced by 
research knowledge.  
 
Mohlman & Gorman (2005) split their sample into Intact EF (all three EF test t-scores 
‘average’ to ‘superior’ range), Executive Dysfunction (EDF) (all three EF tests t-scores 
‘low-average’ to ‘impaired’ range) and Improved EF (three EF test t-scores dysfunction at 
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pre-test and at intact level at post-test). This introduced an interesting perspective into 
considering the impact of EF on CBT outcomes as it suggested that outcome may be 
determined by how static the participant’s EF abilities are. Namely, whether their EF is 
caused by the mental health difficulty or whether difficulties in EF is present independent 
of it. They found that their Improved EF group had a significantly greater decrease than 
EDF on STAI-trait (Mohlman & Gorman, 2005), suggesting those with a static EF are less 
likely to respond to CBT. They acknowledged that due to splitting their sample they were 
underpowered for subsequent results. Goodkind et al’s (2016) surprising result may 
substantiate this; they found that those who performed worse on the WCST predicted a 
better CBT response for depression. They suggested that CBT provided a compensatory 
mechanism for those experiencing difficulties in cognitive flexibility. This supported the 
hypothesis that it may not be possible to predict CBT outcome from EF linearly as 
participant’s EF may not be static.  
 
4.  Discussion 
4.1  Does executive functioning affect CBT outcomes in adults with anxiety 
or mood disorders? 
There is no evidence from the papers, including two papers of ‘strong’ quality, to support 
EF as having a role in CBT response for people with depression. There is mixed evidence 
that EF is associated with outcome of CBT for anxiety: one paper of ‘moderate’ quality 
found that deficits in inhibition (measured by Stroop) predicted a lower CBT response in 
OCD, whereas another paper of the same quality did not find comparable results. Two of 
four papers that focused on OCD, and one GAD focused paper, found that a lower EF 
score predicted CBT response. 
 
How papers approach this question in terms of statistical tests provides a potential 
hypothesis of the role of EF. It appears that using regression or correlation to find a 
relationship between CBT outcomes and EF yields limited results, suggesting two 
possibilities.  
 
First, there may be two types of participants: those with trait-related deficits (independent 
of diagnosis and therefore more static) and those with state-dependent deficits (dependent 
of diagnosis and therefore more flexible). Studies present varying evidence in relation to 
this. Mohlman & Gorman (2005) highlight that amongst their sample there was a 
difference in whether their participants had trait or state EF deficits. If a participant’s EF 
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score did not improve following CBT, it negatively predicted CBT response. However, 
another OCD focused study found that their participants’ EF deficits appear to be trait-
related as they were unchanged even following a decrease in symptoms (Bannon, 
Gonsalvez, Croft & Boyce, 2006). It therefore may be that individuals with trait-related EF 
deficits are less likely to respond to CBT, as Mohlman & Gorman (2005) suggest. This is 
difficult to clarify prior to intervention, but it may be helpful to explore this potential 
relationship by measuring whether individuals with trait-related EF deficits have a poorer 
CBT response.   
 
It should be noted that some of the papers that were excluded by this review’s criteria, 
either due to not directly measuring the relationship between EF and CBT outcomes and/or 
having a therapy adjunct (such as cognitive remediation or problem solving therapy) in 
addition to CBT, may have provided additional knowledge in terms of this state/trait 
debate of EF and how psychological intervention could be adjusted to compensate for this. 
For example, one paper compared neuropsychological functioning pre/post CBT or 
Metacognitive Therapy (MCT). They found that mood and neuropsychological 
improvements were independent from each other and argued that cognitive remediation 
focused interventions (MCT in this case) were beneficial for mood; they suggested if EF 
traits are improved, such as decreased perseveration it leads to an improvement in mood, 
such as decreased rumination in depression or OCD. Consequently, this suggested that 
state-related EF benefited from additional EF related support.  
 
This hypothesis was supported by an article that did not meet the review inclusion criteria 
(Beaudreau et al., 2015) that found older people with depression and deficits in 
inhibitory/attentional control, measured by Trails B, were more likely to respond to 
problem solving therapy (PST) and supportive psychotherapy (SP). They recommended 
that Trails B could be used as a screening cognitive tool to suggest whether a patient needs 
increased support and structure during psychological intervention to augment their 
response, which they argued that PST and SP provided. These findings suggest that CBT 
outcome may not be reliant on whether EF is state or trait, but instead how well the 
intervention incorporates support for EF.    
 
These papers were not included in this review due to the already heterogeneous state of the 
literature. CBT may already provide some scaffolding that help overcome EF deficits, for 
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example through being structured or using visual material, which would support working 
memory and organisation difficulties. This may be why the papers included in this review 
have not suggested a unanimous finding. However, as the literature matures it may be 
possible to conduct a further review that includes additional psychological interventions. 
This would clarify whether EF should be assessed when deciding on the most appropriate 
psychological intervention. It remains to be determined whether patients with lower EF, 
both state and trait, need additional consideration and scaffolding around EF impairments 
to improve their response to psychological intervention; as well as what these adjustments 
would be. 
 
The second possibility is that the relationship between EF and CBT outcome is not linear 
and is perhaps instead a threshold effect for EF (as Mohlman & Gorman, 2005, explored). 
Higher powered studies are needed to explore this hypothesis as it could give helpful 
information in relation to suitability of CBT for levels of EF.   
 
4.2 If EF affects CBT outcomes, what specific aspects/sub-elements are 
relevant to test? 
The studies use a number of different EF tests and three studies present composite scores 
from these tests. Mohlman (2013) argues that single EF test scores are an unreliable 
measure of ability and in their study, they combine the EF scores into verbal and nonverbal 
EF skills. Creating a composite score with multiple tests of EF is suggested as more 
reliable (Crane et al., 2008; Gibbons et al., 2012). This approach is also helpful when 
reviewing because the authors provide an interpretable standardised score rather than raw 
scores. As EF is a complex and multidimensional umbrella term, collapsing an EF score 
into one number may also not be reliable; particularly, when different mental health 
diagnoses indicate different EF difficulties (e.g. OCD and inhibition). As a result, 
composite scores may not capture the particular EF difficulty that the client group 
experience. In future research it may be helpful to create composite scores from multiple 
tasks that aim to measure the same aspect of EF – such as inhibition and interference 
control, working memory and cognitive flexibility - rather than completely collapsing them 
or presenting singular scores.  
 
4.3 Strengths and Limitations  
 23 
 
A strength of this review is that it is the first to synthesise studies that consider the role of 
EF on CBT outcomes. There were limitations relating to the state of the literature, which 
impacted on the conclusions that can be drawn. Firstly, seven of the studies are secondary 
findings of a larger trial and their study design was not tailored around examining EF as a 
predictor. Secondly, the majority of studies did not report a standardised EF score, which 
made it difficult to compare the participant’s baseline EF. This study also did not consider 
other potential confounding factors on the efficacy of CBT, including fidelity to the model, 
competence of therapists and variance of dose. There were also potential confounding 
factors for papers that did not exclude a concurrent pharmacological treatment as 
medication could have an effect on EF scores. These factors could have been considered 
by expanding the quality-rating tool to include questions in relation to these confounding 
variables, so that quality of these papers are considered in relation to these factors. Finally, 
as discussed above, the inclusion criteria meant that papers focused on adjuncts to CBT 
and those that measured EF pre and post intervention were excluded. Although this was 
done to minimise an already heterogeneous set of papers, these excluded papers may have 
provided further information in relation to the state/trait EF debate and whether CBT, or 
other types of psychological therapy, improve EF. Given the heterogeneous nature of this 
literature, there is a need for studies that systematically examine the ways that EF may be 
modified with psychological therapies. This could include CBT based approaches as well 
as other interventions such as Cognitive Remediation Therapy.  
 
4.4 Conclusion 
Despite mixed results, these papers suggested some evidence for EF predicting CBT 
outcomes for anxiety, particularly OCD. As there is variation in response in CBT for 
anxiety there is value in understanding this potential interaction between EF and CBT 
outcomes, particularly in relation to whether there is a threshold effect for EF rather than 
the relationship being linear, and whether individuals with state-dependent EF deficits are 
more likely to respond to CBT. If there is further support for this interaction, it indicates 
that some patients may require more adaptation (James et al., 2008) around their EF 
deficits to help engagement.    
 
5. References 
Armijo‐Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012). 
Assessment of study quality for systematic reviews: a comparison of the Cochrane 
Collaboration Risk of Bias Tool and the Effective Public Health Practice Project 
 24 
 
Quality Assessment Tool: methodological research. Journal of evaluation in 
clinical practice, 18(1), 12-18. 
Bar-Haim, Y., Lamy, D., Pergamin, L., Bakermans-Kranenburg, M. J., & Van Ijzendoorn, 
M. H. (2007). Threat-related attentional bias in anxious and nonanxious 
individuals: a meta-analytic study. Psychological bulletin, 133(1), 1. 
Bannon, S., Gonsalvez, C. J., Croft, R. J., & Boyce, P. M. (2006). Executive functions in 
obsessive–compulsive disorder: state or trait deficits? Australian and New Zealand 
Journal of Psychiatry, 40(11-12), 1031-1038. 
Beaudreau, S. A., Rideaux, T., O'Hara, R., & Arean, P. (2015). Does cognition predict 
treatment response and remission in psychotherapy for late-life depression?. The 
American Journal of Geriatric Psychiatry, 23(2), 215-219. 
Beck, AT., Steer RA., Brown, GK. (1996). Manual for the Beck Depression Inventory, 2nd 
ed. San Antonio, TX, 1996 
Belotto-Silva, C., Diniz, J. B., Malavazzi, D. M., Valério, C., Fossaluza, V., Borcato, S., et 
al. (2012). Group cognitive-behavioral therapy versus selective serotonin reuptake 
inhibitors for obsessive-compulsive disorder: a practical clinical trial. Journal of 
anxiety disorders, 26(1), 25-31. 
Braga, D. T., Abramovitch, A., Fontenelle, L. F., Ferrão, Y. A., Gomes, J. B., Vivan, A. S., 
... & Trentini, C. M. (2016). Neuropsychological Predictors of Treatment Response 
To Cognitive Behavioral Group Therapy In Obsessive–compulsive 
Disorder. Depression and anxiety, 33(9), 848-861. 
Carter, J. D., McIntosh, V. V., Jordan, J., Porter, R. J., Frampton, C. M., & Joyce, P. R. 
(2013). Psychotherapy for depression: a randomized clinical trial comparing 
schema therapy and cognitive behavior therapy. Journal of affective 
disorders, 151(2), 500-505. 
Carter, J. D., McIntosh, V. V., Jordan, J., Porter, R. J., Douglas, K., Frampton, C. M., & 
Joyce, P. R. (2018). Patient predictors of response to cognitive behaviour therapy 
and schema therapy for depression. Australian & New Zealand Journal of 
Psychiatry, 00(0), 1-11.  
Crane, P. K., Narasimhalu, K., Gibbons, L. E., Pedraza, O., Mehta, K. M., Tang, Y., ... & 
Mungas, D. M. (2008). Composite scores for executive function items: 
demographic heterogeneity and relationships with quantitative magnetic resonance 
imaging. Journal of the International Neuropsychological Society, 14(5), 746-759. 
D'Alcante, C. C., Diniz, J. B., Fossaluza, V., Batistuzzo, M. C., Lopes, A. C., Shavitt, R. 
G., ... & Hoexter, M. Q. (2012). Neuropsychological predictors of response to 
 25 
 
randomized treatment in obsessive–compulsive disorder. Progress in Neuro-
Psychopharmacology and Biological Psychiatry, 39(2), 310-317. 
Diamond, A. (2013). Executive functions. Annual review of psychology, 64, 135-168. 
Deckersbach, T., Peters, A. T., Shea, C., Gosai, A., Stange, J. P., Peckham, A. D., ... & 
Nierenberg, A. A. (2018). Memory Performance Predicts Response to 
Psychotherapy for Depression in Bipolar Disorder: A Pilot Randomized Controlled 
Trial with Exploratory Functional Magnetic Resonance Imaging. Journal of 
affective disorders, 229, 342-350. 
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., ... & Friedman, 
J. (2011). Cognitive-behavioral therapy for depression in Parkinson's disease: a 
randomized, controlled trial. American Journal of Psychiatry, 168(10), 1066-1074. 
Dobkin, R. D., Rubino, J. T., Allen, L. A., Friedman, J., Gara, M. A., Mark, M. H., & 
Menza, M. (2012). Predictors of treatment response to cognitive-behavioral therapy 
for depression in Parkinson's disease. Journal of consulting and clinical 
psychology, 80(4), 694. 
Gibbons, L. E., Carle, A. C., Mackin, R. S., Harvey, D., Mukherjee, S., Insel, P., ... & 
Alzheimer’s Disease Neuroimaging Initiative. (2012). A composite score for 
executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative 
(ADNI) participants with baseline mild cognitive impairment. Brain imaging and 
behavior, 6(4), 517-527. 
Goldstein, S., and Naglieri, A. (2014). Handbook of Executive Functioning. New York, 
NY: Springer-Verlag. 
Goodkind, M. S., Gallagher‐Thompson, D., Thompson, L. W., Kesler, S. R., Anker, L., 
Flournoy, J., ... & O'hara, R. M. (2016). The impact of executive function on 
response to cognitive behavioral therapy in late‐life depression. International 
journal of geriatric psychiatry, 31(4), 334-339. 
Groves, S. J., Porter, R. J., Jordan, J., Knight, R., Carter, J. D., McIntosh, V. V., ... & 
Joyce, P. R. (2015). Changes in neuropsychological function after treatment with 
metacognitive therapy or cognitive behavior therapy for depression. Depression 
and anxiety, 32(6), 437-444. 
Hammar, Å., & Årdal, G. (2009). Cognitive functioning in major depression-a 
summary. Frontiers in human neuroscience, 3, 26. 
 26 
 
Hofmann, S. G., & Smits, J. A. (2008). Cognitive-behavioral therapy for adult anxiety 
disorders: a meta-analysis of randomized placebo-controlled trials. The Journal of 
clinical psychiatry, 69(4), 621. 
Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy 
of cognitive behavioral therapy: A review of meta-analyses. Cognitive therapy 
and research, 36(5), 427-440. 
James, I.A., Reichelt, F., Carlsonn, P. & McAnaney, A. (2008). Cognitive Behavior 
Therapy and Executive Functioning in Depression. Journal of Cognitive 
Psychotherapy: An International Quarterly, 22(3), 210-218.  
Julian, L. J., & Mohr, D. C. (2006). Cognitive predictors of response to treatment for 
depression in multiple sclerosis. The Journal of neuropsychiatry and clinical 
neurosciences, 18(3), 356-363. 
Kashdan, T. B., & Rottenberg, J. (2010). Psychological flexibility as a fundamental aspect 
of health. Clinical psychology review, 30(7), 865-878. 
Lezak, M., Howieson, D., & Loring, D. (2012). Neuropsychological assessment. 5th edn 
Oxford University Press: Oxford. 
McLennan, S. N., & Mathias, J. L. (2010). The depression‐executive dysfunction (DED) 
syndrome and response to antidepressants: a meta‐analytic review. International 
journal of geriatric psychiatry, 25(10), 933-944. 
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Prisma Group. (2009). Preferred 
reporting items for systematic reviews and meta-analyses: the PRISMA 
statement. PLoS medicine, 6(7), 1-6.  
Mohlman, J., & Gorman, J. M. (2005). The role of executive functioning in CBT: a pilot 
study with anxious older adults. Behaviour research and therapy, 43(4), 447-465. 
Mohlman, J. (2013). Executive skills in older adults with GAD: Relations with clinical 
variables and CBT outcome. Journal of Anxiety Disorders, 27(1), 131-139. 
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001). 
Comparative outcomes for individual cognitive-behavior therapy, supportive-
expressive group psychotherapy, and sertraline for the treatment of depression in 
multiple sclerosis. Journal of consulting and clinical psychology, 69(6), 942. 
Moritz, S., Birkner, C., Kloss, M., Jahn, H., Hand, I., Haasen, C., & Krausz, M. (2002). 
Executive functioning in obsessive–compulsive disorder, unipolar depression, and 
schizophrenia. Archives of Clinical Neuropsychology, 17(5), 477-483. 
 27 
 
Moritz, S., Kloss, M., Jacobsen, D., Fricke, S., Cuttler, C., Brassen, S., & Hand, I. (2005). 
Neurocognitive impairment does not predict treatment outcome in obsessive–
compulsive disorder. Behaviour Research and Therapy, 43(6), 811-819. 
NHS Education for Scotland (NES). (2015). Mental Health in Scotland: A Guide to 
delivering evidence based Psychological Therapies in Scotland: The Matrix 
2015. NHS Education for Scotland, Edinburgh. 
Pimontel, M. A., Culang‐Reinlieb, M. E., Morimoto, S. S., & Sneed, J. R. (2012). 
Executive dysfunction and treatment response in late‐life depression. International 
journal of geriatric psychiatry, 27(9), 893-899. 
Shin, N. Y., Lee, T. Y., Kim, E., & Kwon, J. S. (2014). Cognitive functioning in obsessive-
compulsive disorder: a meta-analysis. Psychological medicine, 44(6), 1121-1130. 
Thomas, B. H., Ciliska, D., Dobbins, M., & Micucci, S. (2004). A process for 
systematically reviewing the literature: providing the research evidence for public 
health nursing interventions. Worldviews on Evidence‐Based Nursing, 1(3), 176-
184. 
Thompson, D. G., Kesler, S. R., Sudheimer, K., Mehta, K. M., Thompson, L. W., 
Marquett, R. M., ... & O'Hara, R. M. (2015). FMRI activation during executive 
function predicts response to cognitive behavioral therapy in older, depressed 
adults. The American Journal of Geriatric Psychiatry, 23(1), 13-22. 
Tunvirachaisakul, C., Gould, R. L., Coulson, M. C., Ward, E. V., Reynolds, G., 
Gathercole, R. L., ... & Howard, R. J. (2018). Predictors of treatment outcome in 
depression in later life: A systematic review and meta-analysis. Journal of affective 
disorders, 227, 164-182. 
Vandborg, S. K., Hartmann, T. B., Bennedsen, B. E., Pedersen, A. D., & Thomsen, P. H. 
(2014). Are there reliable changes in memory and executive functions after 
cognitive behavioural therapy in patients with obsessive-compulsive 
disorder? Cognitive neuropsychiatry, 20(2), 128-143. 
Vandborg, S. K., Hartmann, T. B., Bennedsen, B. E., Pedersen, A. D., & Thomsen, P. H. 
(2016). Can memory and executive functions in patients with obsessive–
compulsive disorder predict outcome of cognitive behavioural therapy? Nordic 
journal of psychiatry, 70(3), 183-189. 
Wang, Y. P., & Gorenstein, C. (2013). Psychometric properties of the Beck Depression 
Inventory-II: a comprehensive review. Revista Brasileira de Psiquiatria, 35(4), 
416-431. 
 28 
 
Watkins, E., & Brown, R. G. (2002). Rumination and executive function in depression: An 
experimental study. Journal of Neurology, Neurosurgery & Psychiatry, 72(3), 400-
402. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
 
 
 
 
 
 
CHAPTER TWO: MAJOR RESEARCH PROJECT 
 
A Feasibility Study of Group-Based Acceptance and Commitment Therapy with 
Older People with Mental Health Difficulties 
 
Elizabeth Dewey 
 
 
 
 
Mental Health and Wellbeing 
University of Glasgow 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow 
G12 0XY 
 
 
e-mail: elizabethdewey@nhs.net 
 
 
 
 
 
 
 
 
 
Prepared in accordance with the requirements for submission to Cognitive and Behavioural 
Practice (see Appendix 2.1) 
 30 
 
Plain English Summary 
Title: A mixed-methods feasibility study of group-based Acceptance and 
Commitment Therapy with Older People with mental health difficulties 
 
Background: Acceptance and Commitment Therapy (ACT) aims to change a 
person’s relationship with their difficult thoughts rather than change or get rid 
of them (Harris, 2009). This has been suggested to be helpful for older people 
experiencing mental health difficulties as they often experience a number of 
difficulties, including ill-health, which they cannot change (Petkus & 
Wetherell, 2013). There is little research into whether over 65s find ACT 
beneficial for helping with their mental health difficulties. 
 
Study Aims: This study aimed to evaluate the feasibility of running an ACT 
group for older people with mental health difficulties. The research aimed to 
answer the following questions: 
1. Do people agree to take part in the study and attend the group? 
2. Do participants like ACT and what parts are important for them? 
3. Are the questionnaires suitable for the participants and do they show 
improvement?  
 
Method: Participants included patients over 65 years old experiencing mental 
health difficulties. They were recruited from community mental health teams 
or an inpatient mental health ward. Patients were ineligible if they had a 
cognitive impairment or learning disability. Participants were referred to ACT 
groups as part of their routine care. At their pre-group assessment they were 
asked if they would like to take part in research. They were given time to 
consider this and if they agreed, an appointment was set up with the 
researcher to discuss the study further and gather consent to participate in the 
study. The ACT group consisted of 6 sessions, which were 2 hours long.  
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Design of Study: This study used data from questionnaires to find out if 
anything changed for participants (e.g. level of anxiety). Participants were 
asked to complete questionnaires at the researcher appointment before the 
group, after the final session and 12 weeks after the group ended. They also 
completed a short questionnaire after every session. Participants were invited 
to take part in a telephone interview to find out their views about the group.  
 
Main Findings: 14 participants were recruited and 9 completed the group.  
Reasons reported for not attending included physical health difficulties (n=2), 
feeling they improved (n=1), not feeling that the group fit their difficulties 
(n=1), and no reason given (n=1). 7 group completers participated in an 
interview. Questionnaires indicated that after the group, participants’ anxiety 
levels went down and that they did not feel as caught up with difficult 
thoughts. This was supported by the interviews and they noted that they 
particularly enjoyed feeling understood by what was being said by the group 
leaders, being given visual representations of their difficulties, and feeling 
more able to cope with their difficulties.   
 
Conclusion: These results suggest that ACT is beneficial for older people. It 
would be helpful to repeat this study with more participants to find out 
whether the same findings arise.  
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Abstract  
Background: CBT has mixed findings for older people with mental health difficulties and 
has been described as no more efficacious than relaxation training for anxiety. Due to the 
types of difficulties associated with old age that cannot be changed, such as chronic health 
conditions and experiences of bereavement and retirement, a more acceptance-based 
approach, such as Acceptance and Commitment Therapy (ACT) could be more suitable; 
however, there are few clinical trials with ACT and older people.  
Objectives: This feasibility study used mixed methods to explore the acceptability and 
feasibility of delivering ACT groups to inpatient and outpatient older people.  
Method/Results: 14 participants were recruited, nine of these completed the group (defined 
as attending four of six sessions) and eight were interviewed. Results suggested that 12 
weeks after the last session, completers’ anxiety and cognitive fusion scores significantly 
decreased. Interviews suggested that ACT was acceptable to participants.  
Conclusions: ACT is both a feasible and acceptable transdiagnostic intervention for older 
people in an outpatient setting. Preliminary quantitative analysis suggested the intervention 
reduced anxiety and cognitive fusion; however, this should be measured in future 
intervention studies with higher participant numbers. Qualitative analysis suggested older 
people engaged with ACT because of the focus on visual material and that it seemed to 
increase their perspective taking and self-efficacy. The latter needs to be explored 
quantitatively.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Acceptance and Commitment Therapy, Older Adults, Feasibility Study 
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1. Introduction 
It is estimated that by 2040, nearly one in four people in the UK will be over 65 (Age UK, 
2018) and many people within this population experience mental health difficulties 
(Scottish Government, 2001). Consequently, mental health services in the NHS need to 
adapt to the needs of this growing demographic and provide evidence based and acceptable 
interventions for older people.  
 
Research for older people’s psychological treatment has focused on CBT, particularly for 
depression and anxiety, which has been found to be more effective than waiting list control 
conditions, but equivalent to other treatment conditions (Hofmann et al, 2012). However, 
Petkus and Wetherell (2013) have argued that CBT has mixed findings for non-primary 
care older people and for anxiety does not add anything beyond relaxation training (Thorp 
et al., 2009). Studies have explored the difficulties that this client group share and have 
suggested they may use unhelpful thought suppression coping strategies (Petkus, Gum & 
Wetherell, 2012); that is, attempting to stop thinking about a particular thought. This has 
been associated with poorer outcomes (Rosenthal et al., 2005) as thought-suppression can 
produce a ‘rebound’ effect when the frequency of thoughts increases the more they are 
suppressed. Given the mixed CBT evidence there is a need to explore other therapies 
(Roberts & Sedley, 2016). 
 
Acceptance and Commitment Therapy (ACT) is a psychological approach that aims to 
foster willingness to experience unwanted thoughts and feelings without necessarily 
changing their form (Harris, 2009). In this regard, ACT differs from other branches of 
CBT, which explicitly aim to change the content of thoughts as means of reducing 
unwanted symptoms. ACT also includes a strong behavioural component; aiming to help 
clients identify their deeply held ‘values’ and commit to pursuing activity congruent with 
these principles (Harris, 2009). Consequently, ACT aims not to decrease symptoms of 
distress, but to relate differently to them.  
 
It has been argued (Petkus & Wetherell, 2013) that ACT may be well suited for an older 
people population. Roberts and Sedley (2016) suggested a number of reasons why ACT 
may be particularly suitable for older people: the focus on reconnecting with values, which 
older people may have lost touch with as a result of significant life events; complexity of 
presenting difficulties and co-morbidities, requiring a transdiagnostic model; and 
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experience of significant life events, which cannot be changed and therefore require a 
modality that aims to accept these changes. However, the ACT evidence base for older 
people is currently at a very early stage of development. A recent meta-analysis of the 
efficacy of third-wave mindfulness-based therapies (Mindfulness Based Cognitive Therapy 
and ACT) for older people (Kishita, Takei & Stewart, 2017) reported a moderate effect for 
depression symptoms (g=0.55) and anxiety symptoms (g=0.58). Therefore, there is a need 
for studies that develop methods and measures to understand how ACT may be beneficial 
to older people that include ACT specific measures as the aim of ACT is not primarily 
symptom reduction.  
 
As mentioned above, older age is associated with cognitive changes (Harada, Love & 
Triebel, 2013) and an aspect of cognition that may affect engagement with ACT is 
executive functioning (EF). There is no unified definition of EF, but it is generally agreed 
to be high-level cognitive function (Lezak, Howieson & Loring, 2012) comprising three 
core processes (Diamond, 2013): inhibition, working memory and cognitive flexibility; in 
addition to skills relating to these processes, such as reasoning, abstract thought, problem 
solving and planning. There are a limited number of studies with mixed outcomes 
specifically examining the relationship between EF and CBT symptom outcomes for older 
people (Mohlman & Gorman, 2005; Mohlman, 2013). As metaphors are at the core of 
ACT, requiring abstraction and metaphorical thinking, age related declines in EF may be a 
barrier to ACT implementation with older people. Consequently, this feasibility study will 
consider the role of EF in ACT, using a questionnaire measuring understanding of abstract 
concepts.  
 
Research Aims 
The principle objective of this study is to explore the feasibility and acceptability of ACT 
for older people. As this is a feasibility study, the focus is on descriptive and exploratory 
questions consistent with the MRC Complex Interventions Guidance (Craig et al., 2008), 
which describes the key elements of the feasibility/piloting process as: testing procedures 
and estimating recruitment/retention. In addition to exploring preliminary mechanism work 
to establish changes that are associated with treatment signals in an older person 
population. To establish this, it is recommended that using both qualitative and quantitative 
is needed to understand barriers; therefore, this study uses mixed methods. The research 
aims are:    
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1. Population: What are the characteristics of the people who might receive this 
treatment? What are the estimated rates of recruitment and retention of participants 
for future trials?  
2. Intervention: Are ACT groups acceptable to this client group? Does ACT need to 
be adapted? Is taking part in a research trial acceptable to this client group?  
3. Mechanisms for change: What are the possible/likely mechanisms for change 
during the intervention? Can we measure changes in these candidate mechanisms?  
4. Outcome Measures: Can appropriate measures be identified to explore the impact 
of an ACT intervention for older people and are they acceptable and well tolerated 
by patients? 
This information will be used to help the design of future research trials. 
 
2. Method 
2.1 Design 
This study used a mixed methods feasibility design following the MRC Complex 
Intervention framework (Craig et al., 2008). Pre, post and 12-week follow up 
questionnaires were collected for quantitative data and post-group semi-structured 
interviews for qualitative data. As the primary aim was not to determine intervention 
efficacy and intervention groups were treatment as usual, it was not suitable to include a 
control group.  
 
2.2 Participants 
Participants were recruited from an NHS inpatient functional ward for older people, which 
serves all Lanarkshire localities, and two outpatient community mental health teams. ACT 
groups run routinely in these settings and are referred into by clinical treating staff. Prior to 
groups starting, patients were invited to an individual assessment session with one of the 
group facilitators (three qualified Clinical Psychologists). At this session, if they met the 
inclusion criteria described below, they were provided with the participant information 
sheet and asked whether the researcher could contact them after 24 hours to discuss the 
project with them at an appointment. During this appointment, if the client decided they 
wanted to participate, the researcher collected consent, and pre- outcome measures were 
collected at this time. The facilitators were not involved in the researcher appointment or 
post-group interview to minimise bias.  
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Inclusion criteria included: a) Capacity to consent to research; b) 65+ years old; c) 
Inpatients or Outpatients who have been invited to an ACT group; d) Subjective 
psychological distress. Exclusion criteria includes: a) Known learning disability; b) Any 
level of diagnosed cognitive impairment as defined by ICD-10; c) Psychiatric symptoms 
that would be likely to hinder appropriate engagement with the group. 
 
2.3 Sample Size and Analysis 
Based on the three groups planned to run during the recruitment period there were 24-30 
potential group members to recruit. It has been recommended that a minimum of 12 
participants per group should be recruited (Julious, 2005); consequently, although there is 
no control group, this trial will aim to recruit 12 participants. In relation to qualitative 
analysis, thematic analysis was used because of the specific research question and the 
interviews aimed to explore the participant’s personal experience of the group and 
detecting patterns across the interviews. All participants who attended one or more group 
sessions were invited for interview and based on previous research (Braun, Clark & Terry, 
2014), it was expected that saturation for this type of research question would be reached 
following 8-10 interviews.  
 
2.4 Procedure 
2.4.1 Ethical Approval 
Ethical approval (17/WS/0191) was granted by West of Scotland Ethics Committee 1 in 
September 2017 and approved by NHS Lanarkshire Research and Development in October 
2017. All participants gave written informed consent. Two minor amendments were 
sought: one to add a questionnaire that was not provided at the initial meeting (granted 
November 2017) and the other to open recruitment to community groups (granted January 
2018).  
2.4.2 Recruitment 
Recruitment for the first inpatient group began in November 2017 and the group was 
delivered between November-December 2017. Recruitment for the second cycle of was 
between December 2017-January 2018. At this time, no patients were considered eligible 
for referral to the group. Consequently, after an amendment to include outpatient groups, 
recruitment for two groups that were commencing was between January-February 2018. 
These two groups were delivered between March-April 2018.  
2.4.3 ACT Group Protocol 
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A protocol with adaptions for older people was developed by one of the group facilitators 
and another Clinical Psychologist in the department. The protocol comprised of six two-
hour sessions occurring weekly (for the community group) and bi-weekly (for the inpatient 
group). The protocol (Appendix 2.2) was based on a core text (Harris, 2009) and the 
sessions roughly focused on an area of the ACT clinical model. Folders were provided to 
patients with written handouts given out every session. The ACT group was delivered by 
two of three qualified Clinical Psychologists (on rotation).  
 
2.4.4 Measures 
The Brief Experiential Avoidance Questionnaire (Gamez et al, 2014) is a 15-item measure 
of experiential avoidance with an internal consistency mean of α=0.86. It has not been 
previously used in studies with older people.  
The Valuing Questionnaire (VQ) (Smout et al., 2014) is a ten-item measure of values with 
a mean internal consistency mean α=0.95 for successful valued living and α=0.93 for 
disrupted valued living. It has not previously been used in an older adult population.  
The Cognitive Fusion Questionnaire (CFQ) (Gillanders et al., 2014) is a seven-item 
measure of cognitive fusion. This measure has been used with an older adult population 
(Scott et al., 2016) with an internal consistency of α=0.74.  
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) is a 14-
item measure of anxiety and depression with an internal consistency mean of α=0.83 for 
anxiety and α=0.82 for depression (Bjelland et al., 2002).  
A session-by-session measure (Appendix 2.3) was created by the authors (The Acceptance 
and Commitment Therapy measure of change for Older Adults (ACT-OA)), with five 
items, was trialled to measure clarity of values, clarity of planned action, engagement in 
valued living and willingness to experience difficult thoughts and feelings.  
The Therapeutic-Metaphors Interpretation Test (T-MIT) (Hains, 2013) is a six-item 
measure of abstract thinking associated with EF. This measure aims to explore an 
association between this and changes in other measures to consider whether the session 
content needs to be adapted further. 
2.4.5 Data Collection 
Pre-group measures were completed at consent appointment with the researcher. 
Participants were given the ACT-OA to complete at the end of every session. Time was 
given at the end of session six for participants to complete post-measures (all measures 
except for the T-MIT) or participants filled them in between the final session and post-
group interview. Following the group, participants were offered the opportunity to opt-in to 
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attend a qualitative interview. Recordings of interviews were transcribed and anonymised, 
and then deleted to minimise identification. 12-weeks after session six, group completers 
were sent outcome measures to complete and return via post. Demographic and other 
relevant information was collected from participant’s clinical notes.  
 
3. Results 
3.1 Feasibility  
3.1.1 Sample Characteristics 
Three groups were delivered: one inpatient group (group A) and two outpatient groups (B 
and C). In total 14 participants opted into the study: three into the inpatient group (A); four 
into group B; and seven into group C. Four were male (29%) and 10 were female (71%). 
They had a mean age of 70.79 (SD=5.06). Primary reasons for referral included depression 
(n=5), anxiety (n=2), adjustment disorder (n=3), psychosis (n=3), and panic disorder (n=1). 
Ten participants had comorbid diagnoses relating to mental health, including adjustment to 
chronic health conditions (n=5), anxiety (n=4) and depression (n=1). Two participants had 
previously received psychological input and four had current input from a psychiatrist and 
CPN. No participants had previously received ACT.  
3.1.2 Recruitment 
This research originally sought to only include inpatients. However, due to organisational 
factors, such as two functional wards being combined and NHS winter bed pressures, when 
recruitment came to its second cycle, the clinical treating staff indicated the clients were 
too psychologically or physically unwell to be considered for an ACT group. 
Consequently, a minor amendment was made to include older people ACT groups that 
were being run in the community in the same NHS board. This indicated feasibility issues 
relating to recruiting from an inpatient population; however, this issue was rectified 
following this amendment.  
 
A total of 20 patients consented to take part in the group and 14 of these patients consented 
to participate in the study. Overall there was a 50% attrition rate from consent to 12-week 
follow-up. See Figure 1 for details of participant flow, including reasons for not 
consenting. 
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Figure 1. Recruitment Flowchart 
Total 
finished 
group 
(research 
and non-
research) 
(n=12) 
 
Total started 
group 
(research 
and non-
research) 
(n=16) 
 
Total given routine assessment 
appointment for ACT Group 
(n=30) 
 
Total consented to commence ACT 
Group at assessment 
(n=20) 
 
Total agreed to researcher 
appointment 
(n=15) 
Total consented to 
participate in the study 
(n=14) 
 
Total started group 
(n=11) 
 
Total completed group 
(n=9) 
 
Total invited to post-
group interview (n=11) 
Completer (n=9)    
Non-completer (n=2) 
 
Total attended post-
group interview (n=8) 
Completer (n=8)   
Non-completer (n=0) 
 
Total returned 
12-week 
outcomes 
(n=7) 
 
Reasons for not consenting to group (n=10) 
Wanted 1:1 therapy (n=7) 
Travel difficulties (n=2) 
Not interested (n=1) 
 
Reasons for not attending research 
appointment (n=5) 
Felt it would be extra burden (n=3) 
Scheduling issues (n = 2) 
 
Reasons for not consenting to study (n=1) 
Felt it would be extra burden  
 
Reasons for not starting group (n=3) 
Physically unwell (n=1) 
Feel they were better (n=1) 
No reason given (n=1) 
 
Reasons for not completing group (n=2) 
Physically unwell (n=1) (n=3 including 
research and non-research) 
Didn’t feel the group was appropriate for their 
difficulties (n=1) 
 
 
Reasons for not attending interview (n=3) 
Physically unwell to attend (n=2) 
Not contactable (n=1) 
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3.1.3 Attendance 
Of the 14 participants who started the group, three (21.4%) attended all six sessions, five 
(35.7%) attended five sessions, one (7.1%) attended four sessions, one (7.1%) attended two 
sessions, one (7.1%) attended one session. Three (21.4%) did not attend the first session 
following consent and pre-questionnaires. Reasons for non-attendance included physical 
health difficulties (n=1), planned holidays (n=1), funerals (n=1), and in the case of the 
inpatient group, discharge (n=2). 
3.1.4 Group and Questionnaire Completion Rates  
Completion was defined as having attended at least four sessions. Of 14 participants, 11 
started the group and 9 completed (see Figure 1). In group A there were two completers 
(66.7%), in group B there were two completers (66.7%) and in group C there were five 
completers (71.43%). Combining all groups there was a 64.29% completion rate (of those 
who consented to take part in the study). Questionnaires had a 100% completion rate at all 
data points. 
 
Of the 20 patients who initially agreed to attend the ACT group, 16 started and 12 
completed. These numbers include both research consenters and non-consenters. This 
suggests ACT was acceptable for the majority of patients if they commenced the 
intervention. In addition, reasons for drop-out or non-completion were not solely due to 
finding the intervention unacceptable, with the most common reason being due to physical 
health.   
 
3.2 Quantitative Results 
Tests of normality of the outcome measures indicated that non-parametric analysis was 
most appropriate. Wilcoxon Signed-Rank Tests were performed to compare scores (Table 
1).   
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Table 1. Median scores of completers across data collection points, associated Wilcoxon Signed-Rank Tests (WSRT) and effect sizes 
Measure Median (IQR) WSRT:   
Pre-Post 
Effect Size 
(r): Pre-Post 
WSRT:   
Pre-12 
Week 
Effect Size 
(r): Pre-12 
Week 
WSRT: 
Post-12 Week 
Effect Size (r): 
Post-12 Weeks 
 Pre  
(n=14) 
Post 
(n=9) 
12-Week  
(n=7) 
      
HADS          
HADS-A 11 (6) 8 (5) 7.00 (4) Z= -1.96, 
p=0.05* 
0.41 Z= -1.58, 
p=0.16 
0.35 Z= -0.46, 
p= 0.67 
0.12 
HADS-D 9 (3) 6 (6) 7.00 (7) Z= -0.85, 
p=0.40 
0.18 Z= -1.19, 
p=0.24 
0.26 Z= -0.11, 
p=0.92 
0.03 
BEAQ 64 (9) 68 (26) 61.00 (34) Z= -1.42, 
p=0.15 
0.30 Z= -1.52, 
p=0.13 
0.33 Z= -0.76, 
p=0.45 
0.19 
VQ         
VQ-Obstruction 18 (12) 20 (15) 18.00 (15) Z= -1.42, 
p=0.15 
0.30 Z= -0.93, 
p=0.35 
0.21 Z= -0.21, 
p=0.83 
0.05 
VQ-Progress 21 (4) 24 (9) 25.00 (7) Z= -1.02, 
p=0.31 
0.21 Z= -0.85, 
p=0.40 
0.19 Z=-1.24 , 
p=0.21 
0.31 
CFQ 37 (12) 39 (11) 29.00 (19) Z= -1.20, 
p=0.23 
0.25 Z= -2.39, 
p=0.02* 
0.52 Z= -2.37, 
p=0.02* 
0.59 
ACT-OA 20 (7) 24 (9) 25.00 (2) Z= -1.12, 
p=0.26 
0.24 Z= -1.52, 
p=0.13 
0.33 Z= -0.43, 
p=0.67 
0.11 
T-MIT 12 (4.5)         
*significant finding 
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Testing indicated a statistically significant improvement on the HADS-A from pre to post, 
which suggested anxiety decreased with a medium effect size (r=0.41). HADS-A clinical 
cut off scores indicated a clinically significant score from pre to 12-week as the decrease is 
from Moderate (pre) to Non-Clinical (12-week). A significant improvement on the CFQ 
from pre-group to 12-week and post-group to 12-week was also found, with a large effect 
size (r=0.52-59). This indicated participants had lowered cognitive fusion, and that this 
change took place between post and 12-week.  
 
The relationship between EF (as measured by the T-MIT) and the change scores (pre/post 
group) of experiential avoidance (BEAQ), anxiety and depression (HADS), values (VQ), 
and cognitive fusion (CFQ) was investigated using Spearman’s correlation coefficient (see 
Table 2).  
Table 2. Spearman correlation coefficient and p-values of T-MIT with pre to 12-week 
change scores on validated questionnaires 
 HADS-A 
Change 
Score 
HADS-D 
Change 
Score 
BEAQ 
Change 
Score 
VQ 
Obstruction 
Change 
Score 
VQ 
Progress 
Change 
Score 
CFQ 
Change 
Score 
n=7 
Correlation 
with  
T-MIT (r) 
-0.36 -0.30 -0.26 0.07 0.39 -0.21 
p value 0.43 0.52 0.57 0.88 0.39 0.41 
 
No significant results were detected (p-values ranged from 0.39 to 0.88); although, there 
was a medium effect size between T-MIT and HADS-A, HADS-D and VQ-Progress. This 
indicated that a higher score in EF may be related to a decrease in anxiety, depression and 
increase in progress of valued living.   
 
3.3 Qualitative Results: The Participant's Experiences 
3.3.1 Sample Characteristics 
Eight participants opted to attend a post group interview, six were female and two were 
male (mean age=71.63, SD=5.60). All were completers, with a modal dose of five and 
range of two. 
3.3.2 Results 
Thematic analysis was used using Braun and Clarke’s (2006) six-phase process. 
Familiarisation with the data was established through transcription and noting down initial 
ideas. The transcripts were then coded and these codes were collated into potential themes. 
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Following this a thematic map of these themes was created, refined and given examples 
and descriptions within a table. See Table 3 for an outline of candidate and sub-themes. 
Table 3. Candidate Themes and Sub-Themes 
Candidate Theme  Sub-Theme Number of participants who 
expressed this theme  
Acceptability Attitudes towards group  7 
Facilitators  8 
Resonance with content 6 
Mechanisms of Change Self-Perception  7 
Social Context  8 
Awareness of emotions  7 
Acceptance  5 
Aids to Cognitive 
Understanding 
Use of metaphor 8 
Visual  7 
Time to process  5 
Flexible Perspective 5 
 
Theme 1: Acceptability 
Attitudes towards group 
Many participants expressed pre-group anxiety, particularly related to worries that they 
would be forced to talk about their difficulties, or that listening to other people’s 
difficulties would be difficult; however, these difficulties were described as quickly 
alleviated during the first session. 
“[I] was worried at the beginning that hearing other people’s problems were just 
going to make me worse, but it didn’t, it was the complete opposite” (Participant 10, 
p8L5-7) 
A few participants also appeared to view the group as an opportunity to learn new skills, 
which seemed to be more acceptable to them as no participants described the experience as 
therapy. 
“this is actually good groundwork / what I have got now is the skills” (Participant 11, 
p4L4-5 / p6L30) 
Facilitators 
All participants spoke positively about the group facilitators’ qualities, which seemed to 
help participants engage with the group and its contents.  
“[facilitator’s name] had a lovely calm y’know presence I can’t imagine they ever get 
wound up so when they y’know told you to close your eyes and relax it really worked” 
(Participant 14, p2L16-18) 
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A particularly appreciated quality was when facilitators noticed ambivalence around 
understanding on topics and used individual’s examples to explain content in another way.  
“they were very patient and understanding with us…they didn’t go “what?” they were 
so oooh that’s fine, that’s fine and they would say things to make it clearer and that 
it’s just the way you are” (Participant 6, p9L22-25) 
“…and if there was any erm anything that hadn’t been understood or whatever there 
was no hesitation…they would stop and would go round one-to-one and see how we’re 
getting on and just getting stuck with the sentence you’re trying to put and explained 
y’know what it is” (Participant 11, p4L17-23) 
There was also a sense of appreciation about the help participants were receiving and 
putting value and trust into the facilitator’s expertise. 
“they’re well qualified…and earned through and studied for it y’know…those people 
are taking their time to try and help you” (Participant 10, p10L1-3) 
Resonance with Content 
Many participants commented on how the content of the group and the way it was 
delivered made them feel understood or explained their situation.  
“I mean I was sitting saying to myself that’s exactly how I feel (.) that’s exactly how I 
feel” (Participant 7, p2L15-16) 
“just for the information in the handouts I thought well that's what's happening for 
me” (Participant 13, p3L5-6) 
This resonance led some participants to feel that their situation was understood. 
“there is light at the end of the tunnel even if it is speaking to someone and someone 
understanding how you feel” (Participant 7, p5L1-2) 
Theme 2: Mechanisms of Change 
The resonance with content discussed above appeared to be a precursor for the 
mechanisms of change that emerged from the transcripts. 
Self-Efficacy 
Self-efficacy appeared to be an important factor for participants in mediating 
understanding content and translating it to change. Many participants discussed learning 
that they had a role in their recovery when they were asked what they had gained from the 
group and what had changed. 
“me, me is the main thing obviously not saying I’m perfect definitely not but I’m not 
what I would say I’m not perfect and erm there is never a way I would ask to be 
perfect but what I have got now is the skills and I’ve got the support and it’s up to me” 
(Participant 11, p6L28-p7L1) 
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For all but one participant who discussed this sub-theme, this was viewed positively as 
they had more self-efficacious and hopeful attitudes towards themselves. 
“I’ve happily learned (.) I’m stronger within myself yes and that wee group helped me 
to realise” (Participant 6, p2L10-11) 
“I think it’s that instead of me taking these tablets these are short term I’m not 
wanting to be on them for life but I felt that the group and the mindfulness thing is 
something that’s always there you can always bring it back up which is what I’m 
aiming for” (Participant 7, p6L7-10) 
Social Context 
The self-efficacy discussed above was sometimes influenced by how individuals interacted 
with others in the group. Many participants described this experience as normalising. 
“one of the things that was said was that everybody's got a struggle, struggle in life 
and being part of the group made me realise y'know that how true that is” (Participant 
13, p2L25-7) 
“it was interesting hearing other people’s conversation as well problems their 
different problems but same end things y’know I mean experiences” (Participant 10, 
p7L23-5) 
Most of the participants spoke about how they enjoyed being in a group and meeting 
others.  
“it was really pleasant it was like friends meeting up y’know like talking about 
something that we (.) was really nice” (Participant 11, p4L29-31) 
These interactions sometimes led to social comparison in emotional difficulties. A few 
participants discussed feeling comforted by comparing levels of difficulty and social 
support, which had helped in their changes. 
“so what I get from the group is (…) comfort, comfort and not being on my own and 
knowing there’s a lot worse than me” (Participant 6, p9L13-4) 
However, this comparison of social support was not described as helpful for all 
participants. 
“I've come to realise that I don't have any support… so it's not all psychiatric it's 
social” (Participant 13, p2L21-2) 
Awareness of emotions 
In addition to social context and self-perception as being mechanisms of change for 
individuals, many participants acknowledged an increased awareness in how they were 
feeling.  
 46 
 
 
“I didn’t have a clue what was wrong with me I hadn’t a clue how I was feeling” 
(Participant 7, p4L11-2) 
For some, this change was described as being achieved through mindfulness.  
“It brought me to a place where I could think of things and then stand back and just 
realise what was happening” (Participant 3, p2L22-4) 
In addition, a few participants reported that completing the questionnaires had helped them 
become more aware of their feelings, both positively and negatively, which indicated 
increased contact with the present moment.  
“but I think questionnaires are good in the respect that it helps me as well, knowing as 
well as yourself that it helps you to know er how you're going and what you're doing” 
(Participant 3, p5L27-9) 
“it made me realise when I was filling in the questionnaires how ill I am” (Participant 
13, p5L21-2) 
Acceptance 
Acceptance seemed to be a mechanism of change that followed from awareness of 
emotions. For example, the following example illustrates how one participant became 
aware of their difficulties and how experiential avoidance through distraction had helped in 
the short-term but that following retirement it exacerbated their difficulties.  
“I think what was wrong with me is I didn’t deal with what was wrong with me…or 
what happened to me years ago. I didn’t deal with my problem or how I felt and I had 
a busy job so that busy job kept me going and distracted so my problem wasn’t there 
all the time, and when I retired and I had nothing else but my problems went through 
my mind, and I really didn’t feel good at all in myself I really felt terrible in myself” 
(Participant 7, p4L23-8) 
The following quote illustrated the same participant’s more accepting stance towards their 
difficulties and feelings following the group. 
“I’m realising that what’s happened is there y’know you can’t do anything about it 
and it’s got to be about what’s here and what’s coming, so I feel ok now about 
thinking about the past but I move on from it I feel more relaxed I certainly don’t have 
the anxiety I had… and I’ve just had to say to myself that I can’t change what’s 
happened and I just have to deal with it in a different way I’ve just got to get on with 
my life”” (Participant 7, p6L22-25, p6L30-p7L1) 
Similar sentiments were echoed by many other participants, for example discussing how 
they now confront and “deal with” their difficulties rather than attempting to get rid of 
them.   
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“it helped me deal with some of the things I had in my mind it really did” (Participant 
3, p1L4-5) 
“I just got to get on with that just try and accept it’s there” (Participant 10, p6L20-1) 
Others described acceptance of their ‘off days’ and emotions.  
“whatever happens, whatever happens happens” (Participant 3, p2L18-9) 
“There are days I feel [depressed]…we all feel we do” (Participant 6, p3L18) 
Although there was a number of examples of acceptance, participants also acknowledged 
that it was difficult and would result in frustration of trying to get rid of their difficulties.  
“they [other group members] were quite frustrated y’know and they’ll do anything 
these people do anything to get rid of it y’know and sometimes they get frustrated 
because it’s not happening” (Participant 10, p7L26-8) 
Another participant said acceptance had meant they were no longer ruminating about their 
difficulties.  
“I keep hanging onto things and I couldn’t let them go and I saw that [metaphor] and 
I thought that is me… It tells me right you don’t need this you don’t need this, move 
on, right you can do this, you’ve done a lot more than this and I talk myself through it 
(.) and that it is it doesn’t sound maybe natural but it was letting go of the rope” 
(Participant 6, p2L19-20, 27-8) 
Theme 3: Aids to Cognitive Understanding 
Use of Metaphor 
Many metaphors within the group were around acceptance of emotional struggle, and the 
previous quote highlighted a participant using metaphor to describe this struggle with 
acceptance. All participants cited a metaphor during their interview when asked about the 
group, highlighting it was an important aspect for them. Use of metaphors appeared to be 
an important part of helping participants to understand complex concepts; some 
participants explicitly acknowledged this. 
“well the pictures I liked that they put things in a simple way… there was a monster 
and a boy (.) that put things simply” (Participant 14, p1L25, p2L1) 
There seemed to be three levels of understanding in relation to the metaphors. Firstly, all 
participants were able to remember and concretely describe a metaphor. 
“all it meant was you couldnae beat the monsters at the end of it” (Participant 2, 
p1L26-7) 
Some participants were able to describe how the metaphor related to emotional difficulties.  
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“they did go through all of the things about the elephant in the room and the tug of 
war thing where you’re tugging with your emotions constantly erm and how you could 
deal with that and how you think you could deal with that” (Participant 7, p2L9-12) 
A couple of participants were able to specifically describe their own situation using the 
metaphor and describe how to use this to facilitate acceptance, which was illustrated above 
(Participant 6, p2L19-20, 27-8). Consequently, it seems that metaphors were an important 
part of remembering and understanding concepts for all participants, but that there were 
different levels of abstract thinking around the metaphors.  
Visual  
Alongside finding that metaphors explained situations simply, participants commented on 
their visual nature, alongside other visual aspects of the group, such as handouts and 
writing on the whiteboard. For example, Participant 3 suggested that when information was 
presented visually it helped subsequent recollection.   
“…the way it was done especially with the monster it gave you an idea sometimes 
things like that that look more simple that they're actually better for you because you 
can visualise that in your mind's eye and you think about that oh yeah the bus, the bus 
idea” (Participant 3, p3L12-5) 
Other participants indicated that visual material helped concepts become more concrete 
and facilitate understanding. 
“I think when you physically see something that definitely helps” (Participant 3 
p4L27-8) 
“putting it in black and white up on the board to see as well as having a handout to 
follow” (Participant 13, p4L16-7) 
"taking notes or being able to see notes that was really important because the way that 
the people erm (.) like [facilitator's name] or [facilitator's name] they're giving the 
information erm and where we're going and what we're doing but I really need to get 
notes because there's no way I can carry that in my head” (Participant 11, p2L16-20) 
A number of participants discussed the session-by-session visual handouts as being helpful 
and said they referred to them outside of sessions. 
“I do think about what they said in the group I do fall back on it and say well I got my 
wee folder and I do fall back on it” (Participant 7, p5L9-10) 
Time to Process 
In relation to using the handouts between sessions, time was identified as a theme that 
participants said helped them to socialise to the model and cognitively process content. 
Some participants indicated they found the content difficult during the sessions but that 
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they used the time in between sessions to think about material, which helped their 
understanding.  
“but I must say they didn’t always sink in there I’m more a thinker at night when I’m 
sitting and it would and I would get the things all out and I’d go right that was that, 
that was that, and it did eventually sink in” (Participant 6, p4L7-10) 
“and the language y'know to pick up and that but I did catch on... I think it took me 
until the third week before I was starting to get a wee bit more about it” (Participant 
11 p1L5-6, 8-9) 
This suggested that number of sessions attended and time between them were important for 
participants to engage with content.  
Flexible Perspective 
Another subtheme that seemed to be an important cognitive aspect for some participants 
was acknowledging that the model presented another perspective.  
“I just enjoyed going to it I felt as though they were erm giving me answers that I 
didn’t have before telling me how to deal with things telling me right you’re maybe 
feeling like this but you can also do that showing me that different ways to deal with 
my emotions” (Participant 7, p4L8-11) 
In addition, some of these participants had taken the different perspective and assimilated it 
with their own.  
“although I now don't seem to go down that road anymore it's as if my mind's going a 
different way now” (Participant 3 p4L24-5) 
This change in perspective, and defusion from their “mind’s” thoughts, may have helped to 
mediate the change described in Theme 2.  
 
4. Discussion 
This study provides one of the first explorations of the feasibility and acceptability of ACT 
for older people. Feasibility was assessed through gathering information on recruitment 
and retention of participants presenting with mixed anxiety and depression related 
problems. Acceptability was determined through quantitative questionnaires and 
qualitative interviews to consider potential mechanisms of change and participants’ views 
on the group. 
 
4.1 Feasibility 
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Recruitment in the initial phase revealed a lack of patients who were appropriate for 
inpatient ACT groups. Consequently, it was found to be unfeasible to recruit from this 
setting and an amendment was made to include outpatients. Following this amendment, 
recruitment improved, which indicates it is more feasible to conduct research in outpatient 
ACT groups and that this population are more suitable for this intervention.  
 
The observed attrition rate was high with three participants not attending the first session, 
two dropped out by session three and two did not return the 12-week questionnaires. This 
was comparable to a pilot study that offered ACT groups within a nursing home (Alonso et 
al., 2013) and reported a 49.06% (n=26) attrition rate. Reasons for drop out (physical 
health, feeling they no longer needed it and that it was not suited for their difficulties) were 
also comparable, indicating these issues are common within this population. Future trials 
may need to consider the impact of chronic health problems within the design of their 
studies. Outcome measure completion rate was good, meaning all data could be analysed, 
and that the session-by-session measure was not burdensome.  
 
4.2 Acceptability 
Attrition rates for the research arm of the trial between consent and group finishers was 
35.7% and in the routine data arm was 25%. Although comparable to a pilot study with a 
similar client group (Alonso et al., 2013) it suggested that there may be high attrition in 
future studies with this client group. As the largest reason for drop-out or not starting the 
group was physical health difficulties, it may indicate that adjustments may need to be 
made for clients who have more severe physical health difficulties in future studies. This 
could be addressed within the exclusion criteria to include that clients who have a physical 
health difficulty that prevents them from being able to commit at least four sessions will be 
directed to individualised support to take these difficulties into account. This would be 
with the view that should the client's situation change in the future they could be included 
in future groups. In addition, physical health could be further considered within the 
assessment stage of the ACT group (prior to the appointment with the researcher). As ACT 
has been identified as an effective intervention for individuals with long term health 
conditions (Roberts & Sedley, 2016), it may be helpful to emphasise explicitly the 
transdiagnostic application of ACT for both mental health and physical health difficulties, 
as often for this population they are co-morbid. In addition, to support this the protocol 
could be further adapted to include discussion about application of the principals to both 
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physical and mental health. These adjustment considerations within future trials may help 
to improve attrition, which would in turn give a greater estimate of response to ACT. 
 
The good completion rate on outcome measures indicated they were acceptable; when 
directly asked during interview about their experience of completing questionnaires, there 
was no negative feedback following this question and many participants commented on 
their helpfulness in measuring how they were feeling. 
 
In the interviews, participants described ACT as relatable and consequently acceptable 
because of its use of examples and metaphors that resonated with their situations. This 
acceptability, together with the cognitive adjustments, through visual methods (using the 
whiteboard, handouts and some visual metaphors) for concreteness and memory aid and 
time between sessions to process, allowed participants to view their difficulties from 
another standpoint. These features of acceptability and cognitive understanding led to 
change if they had self-efficacy about their ability to change and social support to scaffold 
this. This may have enabled individuals to become more aware of their feelings and 
emotions through mindfulness and questionnaires, and some were able to take a more 
accepting approach to their difficulties with the use of metaphors and seeing themselves as 
able to make changes. This may be associated with self-as-context, which is a part of the 
ACT model that describes the concept that individuals can gain perspective through 
noticing. A change in self-as-context through ACT intervention has been suggested to be 
associated with improved functioning (Yu, Norton & McCracken, 2017), and these 
qualitative interviews may support this. Sub-themes may have acted as mediators for 
different candidate themes, and this is represented in the Venn diagram below (Figure 2). 
The function of a group rather than individual therapy also seemed to be an important 
factor as individual’s emotional struggles were normalised and the group was viewed as 
supportive. These findings are consistent with another study that interviewed older 
people following an ACT group intervention (Jacobs, Luci & Hagemann, 2017). 
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Figure 2. Venn diagram of Sub-Themes that mediated Candidate Themes  
 
Exploratory analysis showed a clinically significant change between pre and 12-week from 
‘Moderate’ anxiety to ‘Non-Clinical’ with a medium effect size. This effect of ACT having 
more of an effect on anxiety than depression has been found in other studies (Hofmann et 
al., 2010). It perhaps reflects ACT’s focus on acceptance (rather than experiential 
avoidance) meaning ‘difficult’ emotions (such as depression) are expected to remain but 
that clients are more willing to tolerate and accept these emotions, which may lead to 
decreased anxiety about the emotions (Harris, 2006). Qualitative interviews suggested 
some acute anxiety about starting the group itself, which may have elevated baseline 
scores. It therefore may be helpful to administer the HADS after session one to consider 
whether pre-group anxiety influences participants’ scores. 
 
CFQ scores significantly decreased with a large effect size, between pre and 12-week with 
the change taking place between post and 12-week, signalling that cognitive defusion was 
a mechanism of change. This delay may be as a result of the importance of ‘time to 
process’ that participants discussed in interview. In addition, it may signal that a decrease 
in anxiety could be linked to subsequent cognitive defusion. As a feasibility study, the 
empirical outcomes were not being used to examine statistically significant changes in 
patient test scores. Rather, we set out to use change scores and measures of dispersion in 
the data to provide signals that could guide hypotheses and power calculations for future 
trials. Because of these considerations, a Bonferroni Correction was not applied as this 
would increase the possibility of a Type II error. In line with recommendations (Perneger, 
1998), as this correction was not applied, statistical tests were described, and caution has 
been used when interpreting the results.  
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Petkus and Wetherell (2013) suggested that older people are more likely to engage with 
values rather than the concept of emotional struggle; however, interviews suggested that 
participants identified most with the metaphors around emotional struggle and tests 
indicated no significant change on the Valuing Questionnaire. Interestingly, correlations 
revealed a medium effect size between higher EF and increased progress with values, 
which may exist because the identification of values, and subsequent committed action, 
requires multiple aspects of EF such as mental flexibility, organisation and planning. As 
interviews highlighted that aids to cognitive understanding– such as time to process, 
offering alternative perspectives and visual concrete examples and handouts- were 
important, these findings may suggest that more adaptation is needed to aid patients with 
lower EF to engage with values. 
 
4.3 Strengths and Limitations 
A main limitation for this feasibility study was low participant numbers, as it has been 
found that the average sample size of feasibility studies is 30 (Billingham, Whitehead & 
Julious, 2013). This was a result of unforeseen systemic difficulties within the NHS that 
occurred during recruitment resulting in patients who were inappropriate for ACT. 
Although, this also provided helpful information about the difficulties around recruiting in 
these settings. An additional limitation was that intention-to-treat (ITT) analysis was not 
applied when conducting the exploratory analyses. Only data from treatment completers 
were used in order to address the study aim of exploring the potential mechanisms of 
exhibited by participants. If participants who had not received the treatment had been 
included the study may have been susceptible to a Type II error. As this understanding of 
this treatment approach increases, ITT analyses should be included in future clinical trials. 
This will include data from people who drop-out or do not comply with all study 
procedures and so will provide a clearer reflection of clinical practice. Hence, as this 
literature develops, it will be more appropriate to use designs that decrease the chance of a 
Type I error. 
 
A strength of this study is that it amalgamated qualitative and quantitative analysis to 
examine whether ACT is acceptable for older people in line with recommendations (MRC, 
2000). As a result, it has given a greater understanding of what has worked for participants, 
particularly in relation to cognitive adaptations. Although older age is related to a change 
in EF, which could be assumed to make aspects of ACT more difficult, such as using 
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metaphor and increasing flexibility around difficulties, the interviews indicated that for 
many participants the metaphors resonated with them and they recognised the facilitator’s 
flexible perspective. The interviews were also able to detect a subtle change in 
understanding of metaphors between participants (concrete understanding, abstract 
understanding and understanding in relation to own situation) as described in the results 
section, which may be a difference that has a role in outcome.  
 
4.4 Future Research 
According to MRC (Craig et al., 2008) guidance in developing complex interventions, the 
next step following feasibility is to undertake a pilot study to examine the key uncertainties 
following a feasibility study. The key uncertainties from this study are: if significant results 
would occur with a control group and a larger sample; how values can be conveyed more 
concretely; and how the self can become more flexible, efficacious and compassionate, as 
this seemed to be an important mediator in this study in bridging understanding of the 
intervention to bringing about change. The importance of increases in self-efficacy is 
consistent with the suggestions of Arch and Craske (2008), that acceptance-based 
interventions may somewhat paradoxically increase individuals' perceived prediction and 
control of symptoms.  
 
4.5 Conclusion 
ACT is both a feasible and acceptable transdiagnostic intervention for older people in an 
outpatient setting. The protocol developed by the facilitators had appropriately adapted 
material to allow cognitive changes associated with older age as measured by the 
qualitative analysis. Although, sessions around values may need to be further adapted. 
Preliminary quantitative analysis suggested that the intervention reduced anxiety and 
cognitive fusion; however, this should be measured in future intervention studies with 
higher participant numbers. Qualitative analysis suggested older people resonated with the 
ACT material because of the focus on visual material and that it seemed to increase their 
perspective taking and self-efficacy. The latter needs to be explored quantitatively.   
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country name, and, if available, the e-mail address of each author. 
 Corresponding author. Clearly indicate who will handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that telephone 
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and fax numbers (with country and area code) are provided in addition to the 
e-mail address and the complete postal address. 
 Present/permanent address. If an author has moved since the work described in the 
article was done, or was visiting at the time, a "Present address" (or "Permanent 
address") may be indicated as a footnote to that author's name. The address at 
which the author actually did the work must be retained as the main, affiliation 
address. Superscript Arabic numerals are used for such footnotes. 
Abstract  
 
A concise and factual abstract is required. The abstract should state briefly the purpose of 
the research, the principal results and major conclusions. An abstract is often presented 
separately from the article, so it must be able to stand alone. For this reason, References 
should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard 
or uncommon abbreviations should be avoided, but if essential they must be defined at 
their first mention in the abstract itself. The abstract should not exceed 200 words in length 
and should be submitted on a separate page following the title page. 
Graphical abstract  
Although a graphical abstract is optional, its use is encouraged as it draws more attention 
to the online article. The graphical abstract should summarize the contents of the article in 
a concise, pictorial form designed to capture the attention of a wide readership. Graphical 
abstracts should be submitted as a separate file in the online submission system. Image 
size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or 
proportionally more. The image should be readable at a size of 5 × 13 cm using a regular 
screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You 
can view Example Graphical Abstracts on our information site. 
Authors can make use of Elsevier's Illustration Services to ensure the best presentation of 
their images and in accordance with all technical requirements. 
Highlights  
Highlights are mandatory for this journal. They consist of a short collection of bullet points 
that convey the core findings of the article and should be submitted in a separate editable 
file in the online submission system. Please use 'Highlights' in the file name and include 3 
to 5 bullet points (maximum 85 characters, including spaces, per bullet point). You can 
view example Highlights on our information site. 
Keywords  
 
Include a list of four to six keywords following the Abstract. Keywords should be selected 
from the APA list of index descriptors unless otherwise approved by the Editor. 
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed on the first 
page of the article. Such abbreviations that are unavoidable in the abstract must be defined 
at their first mention there, as well as in the footnote. Ensure consistency of abbreviations 
throughout the article. 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the title or 
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otherwise. List here those individuals who provided help during the research (e.g., 
providing language help, writing assistance or proof reading the article, etc.). 
Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to funder's requirements: 
Funding: This work was supported by the National Institutes of Health [grant numbers 
xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and 
the United States Institutes of Peace [grant number aaaa]. 
It is not necessary to include detailed descriptions on the program or type of grants and 
awards. When funding is from a block grant or other resources available to a university, 
college, or other research institution, submit the name of the institute or organization that 
provided the funding. 
If no funding has been provided for the research, please include the following sentence: 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
Math formulae  
Please submit math equations as editable text and not as images. Present simple formulae 
in line with normal text where possible and use the solidus (/) instead of a horizontal line 
for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. 
Powers of e are often more conveniently denoted by exp. Number consecutively any 
equations that have to be displayed separately from the text (if referred to explicitly in the 
text). 
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the article. 
Many word processors build footnotes into the text, and this feature may be used. Should 
this not be the case, indicate the position of footnotes in the text and present the footnotes 
themselves separately at the end of the article. 
Artwork 
Electronic artwork  
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Indicate per figure if it is a single, 1.5 or 2-column fitting image.  
• For Word submissions only, you may still provide figures and their captions, and tables 
within a single file at the revision stage.  
• Please note that individual figure files larger than 10 MB must be provided in separate 
source files. 
A detailed guide on electronic artwork is available. 
You are urged to visit this site; some excerpts from the detailed information are given 
here.  
Formats  
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Regardless of the application used, when your electronic artwork is finalized, please 'save 
as' or convert the images to one of the following formats (note the resolution requirements 
for line drawings, halftones, and line/halftone combinations given below):  
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'.  
TIFF (or JPG): Color or grayscale photographs (halftones): always use a minimum of 300 
dpi.  
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum of 
500 dpi is required.  
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the 
resolution is too low.  
• Supply files that are too low in resolution.  
• Submit graphics that are disproportionately large for the content. 
Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or 
PDF), or MS Office files) and with the correct resolution. If, together with your accepted 
article, you submit usable color figures then Elsevier will ensure, at no additional charge, 
that these figures will appear in color online (e.g., ScienceDirect and other sites) regardless 
of whether or not these illustrations are reproduced in color in the printed version. For 
color reproduction in print, you will receive information regarding the costs from 
Elsevier after receipt of your accepted article. Please indicate your preference for color: 
in print or online only. Further information on the preparation of electronic artwork. 
Figure captions  
Ensure that each illustration has a caption. A caption should comprise a brief title (not on 
the figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used. 
Tables  
 
Please submit tables as editable text and not as images. Tables can be placed either next to 
the relevant text in the article, or on separate page(s) at the end. Number tables 
consecutively in accordance with their appearance in the text and place any table notes 
below the table body. Be sparing in the use of tables and ensure that the data presented in 
them do not duplicate results described elsewhere in the article. Please avoid using vertical 
rules and shading in table cells. 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and 
vice versa). Any references cited in the abstract must be given in full. Unpublished results 
and personal communications are not recommended in the reference list, but may be 
mentioned in the text. If these references are included in the reference list they should 
follow the standard reference style of the journal and should include a substitution of the 
publication date with either 'Unpublished results' or 'Personal communication'. Citation of 
a reference as 'in press' implies that the item has been accepted for publication. 
Web references  
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
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source publication, etc.), should also be given. Web references can be listed separately 
(e.g., after the reference list) under a different heading if desired, or can be included in the 
reference list. 
Data references  
This journal encourages you to cite underlying or relevant datasets in your manuscript by 
citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add [dataset] 
immediately before the reference so we can properly identify it as a data reference. The 
[dataset] identifier will not appear in your published article. 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and any 
citations in the text) to other articles in the same Special Issue. 
Reference management software  
Most Elsevier journals have their reference template available in many of the most popular 
reference management software products. These include all products that support Citation 
Style Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word 
processor plug-ins from these products, authors only need to select the appropriate journal 
template when preparing their article, after which citations and bibliographies will be 
automatically formatted in the journal's style. If no template is yet available for this 
journal, please follow the format of the sample references and citations as shown in this 
Guide. If you use reference management software, please ensure that you remove all field 
codes before submitting the electronic manuscript. More information on how to remove 
field codes. 
Reference formatting  
There are no strict requirements on reference formatting at submission. References can be 
in any style or format as long as the style is consistent. Where applicable, author(s) 
name(s), journal title/book title, chapter title/article title, year of publication, volume 
number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article 
by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for 
the author to correct. If you do wish to format the references yourself they should be 
arranged according to the following examples: Oguro, M., Imahiro, S., Saito, S., 
Nakashizuka, T. (2015). Mortality data for Japanese oak wilt disease and surrounding 
forest compositions. Mendeley Data, v1. http://dx.doi.org/10.17632/xwj98nb39r.1 
Supplementary material  
 
Supplementary material such as applications, images and sound clips, can be published 
with your article to enhance it. Submitted supplementary items are published exactly as 
they are received (Excel or PowerPoint files will appear as such online). Please submit 
your material together with the article and supply a concise, descriptive caption for each 
supplementary file. If you wish to make changes to supplementary material during any 
stage of the process, please make sure to provide an updated file. Do not annotate any 
corrections on a previous version. Please switch off the 'Track Changes' option in 
Microsoft Office files as these will appear in the published version. 
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Research data  
 
This journal encourages and enables you to share data that supports your research 
publication where appropriate, and enables you to interlink the data with your published 
articles. Research data refers to the results of observations or experimentation that validate 
research findings. To facilitate reproducibility and data reuse, this journal also encourages 
you to share your software, code, models, algorithms, protocols, methods and other useful 
materials related to the project. 
Below are a number of ways in which you can associate data with your article or make a 
statement about the availability of your data when submitting your manuscript. If you are 
sharing data in one of these ways, you are encouraged to cite the data in your manuscript 
and reference list. Please refer to the "References" section for more information about data 
citation. For more information on depositing, sharing and using research data and other 
relevant research materials, visit the research data page. 
Data linking  
If you have made your research data available in a data repository, you can link your 
article directly to the dataset. Elsevier collaborates with a number of repositories to link 
articles on ScienceDirect with relevant repositories, giving readers access to underlying 
data that gives them a better understanding of the research described. 
There are different ways to link your datasets to your article. When available, you can 
directly link your dataset to your article by providing the relevant information in the 
submission system. For more information, visit the database linking page. 
For supported data repositories a repository banner will automatically appear next to your 
published article on ScienceDirect. 
In addition, you can link to relevant data or entities through identifiers within the text of 
your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; 
CCDC: 734053; PDB: 1XFN). 
Data statement  
To foster transparency, we encourage you to state the availability of your data in your 
submission. This may be a requirement of your funding body or institution. If your data is 
unavailable to access or unsuitable to post, you will have the opportunity to indicate why 
during the submission process, for example by stating that the research data is confidential. 
The statement will appear with your published article on ScienceDirect. For more 
information, visit the Data Statement page. 
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Appendix 1.2 Full Search Strategy 
 String  
Search 
Terms: 
Subject 
Headings 
S1 Executive Function* 
S2 Cognitive Behavior Therapy 
Search Terms 
(Keywords, 
Title, 
Abstract) 
S3 
 
 
(executive function* or dysexecutive function* or executive skills or 
neuropsych* predictors or executive deficits or predictors of treatment 
response) 
S4 (cbt or cognitive behavio* therapy or Third wave or 3rd wave or 
(acceptance n2 commitment therapy) or cognitive therapy or 
behavio?ral activation or cognitive behavio?ral analysis system of 
psychotherapy or dialetical behavio* therapy or meta cognitive therapy 
or metacognitive therapy or mindfulness based cognitive therapy or 
schema therapy or functional analytic psychotherapy or integrative 
behavio?r couple therapy or compassion focussed therapy or 
compassionate mind training or motivational interviewing) 
Combination 
of Search 
Terms 
S5 S1 OR S3  
S6 S2 OR S4 
S7 
(Final) 
S5 AND S6 
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Appendix 1.3 Data Extraction Form 
Article Code __ 
Based on NICE data extraction form (BPS  & Gaskell 2007) 
Extraction Item Details 
Citation 
 
 
Reviewer  
Type of Study 
Type and part of bigger trial? 
 
Study country  
Ethical standards  
Study Aims   
Sample 
Inclusion criteria  
Exclusion Criteria  
Participant Characteristics: 
Comorbidities; Previous/ 
concurrent treatments 
 
 
 
Sample Type and where 
recruited from 
 
 
Important differences 
between groups and was this 
controlled for? 
 
Was recruitment % reported  
Sample size and groups  
CBT type  
CBT Protocol Description  
Control Group Description  
(if applicable) 
 
 
Ethical considerations  
Allocation 
Randomisation and blinding  
(if applicable) 
 
 
 
Data Collection 
Executive Functioning 
Measures / What it measures 
 
 
 
 
Other Neuro Measures  
Symptom Measures  
Methods  
Data Analysis 
Analysis 
Type of analysis 
 
 
Attrition (%)  
Finding Summary  
Findings 
Implications  
Strengths  
 
Limitations   
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Appendix 1.4 Full inclusion/exclusion criteria 
Author/Year Inclusion Exclusion 
Braga et al (2016) + 18-65 Years 
+ Primary diagnosis    of OCD (SCID-I) 
+ 16+ on Y-BOCS 
- Lifetime diagnosis of neurological disorders 
- Psychosis, ASD, ID 
- Current alcohol or drug abuse 
Carter et al., (2018) + 18 years and over 
+ MDD (SCID) 
+ Free of centrally acting drug other than hypnotic and 
contraception  
- Schizophrenia or bipolar diagnosis 
- Major medical condition 
- Failure to respond to trial of CBT/ST in the past year 
D’Alcante et al (2012) + 18-65 Years 
+ Primary Diagnosis of OCD (DSM-IV) 
- Prior exposure to psychotropic medication or CBT 
- General medical condition 
- Severe mental illness other than OCD 
Deckersbach et al 
(2018) 
+ English Speakers 
+ 18-65 Years 
+ Diagnosis of Bipolar I (DSM-IV) 
+ Current MDD 
+ Stable Pharmacology  
 
- Previous CBT treatment 
- Rapid cycling or current mixed episode Bipolar Disorder subtype 
- fMRI contraindications 
- Serious medical conditions 
- Neurological disorder (including TBI) 
- Lifetime schizophrenia spectrum disorder 
- Substance/alcohol use disorder within the last year 
- IQ < 80 (measured on WART) 
Dobkin et al (2012) + Parkinson’s disease by research criteria    
+ Primary Major Depression, Dysthymia, or 
Depression NOS per the SCID DSM-IV   
+ CGI-S ≥ 4   
+ Ages 35–85  
+ Stable medication regimen ≥ 6 weeks   
+ Family member or friend willing to participate.   
- Dementia [score below 5th percentile for age on memory and at least one 
other subscale on the Mattis Dementia Rating Scale)    
- Offtime ≥50% of the day  
- Suicidal Ideation  
- Unstable medical conditions  
- Bipolar, Psychotic Spectrum, or Substance Abuse Disorders (DSM-IV); -
 Receiving CBT elsewhere.  
Goodkind et al (2016) + 60+ years - Active suicidality 
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+ Diagnostic criteria for minor/major depression 
+ 15+ on CES-D 
+ Primary diagnosis of major depression or dysthymia on 
MINI 
 
- Psychosis 
- Substance/alcohol abuse  
- Manic episode in last year 
- <25 on MMSE 
Julian & Mohr (2006) + Diagnosis of MS: relapsing-remitting or secondary 
progressive disease course 
+ Diagnosis of current MDD (SCID) 
+ 16+ on HAM-D and BDI 
+ No other psychological or pharmacological treatment 
during study 
 
- DSM-IV Axis I psychiatric disorder other than MDD or GAD 
- <5th percentile on 3/6 cognitive domains 
- Severe suicidal ideation 
- Corticosteroid treatment within 30 days 
- Initiation of treatment with an interferon medication within previous 2 
months 
- Current MS exacerbation 
- Head Injury or neurological disorder other than MS 
- Current or planned pregnancy 
- Impairment in visual acuity precluding assessment 
- Current psychological or pharmacological treatment for depression 
Mohlman & Gorman 
(2005) 
+ 60+ years 
+ Diagnosis of GAD (DSM-IV) 
+ Read and write in English 
 
- Suicidality last 6 months 
- Concurrent treatment 
- Never experienced psychotic symptoms  
- No antidepressants or anxiolytics 
Mohlman (2013) + 60+ years 
+ Diagnosis of GAD (SCID) 
+ +24 on MMSE 
+ Average or better range in BNT 
- No anxiety medication 
Moritz et al (2005) + OCD Diagnosis (DSM-V) using neuropsychiatric 
interview 
+ 18+ 
- Somatic or psychopathological syndromes 
Vandborg et al (2016) + OCD Diagnosis (DSM-IV) 
+ 18-60 Years 
+ Danish native language 
+ 16+ Y-BOCS 
 
- Neurological and psychiatric co-morbidity except anxiety disorders 
secondary to OCD and Cluster C personality disorders 
- HDRS > 17 
- Pharmalogical treatment other than SRIs 
Onset of treatment with SRIs less than 3 months before onset of CBT 
 
 
 69 
 
 
Appendix 1.5 Quality Ratings 
 
Ratings: 
1 = Strong 
2= Moderate 
3 = Weak                
            
Global 
Rating 
A. Selection 
Bias 
B. Study 
Design 
C. Confounders D. Blinding E. Data 
Collection 
Methods 
F. Withdrawal 
and Drop-Outs 
Number of 
EF Tests 
Braga et al  
(2016) 
       2 
Carter et al., 
(2018) 
       4 
D’Alcante et al 
(2012) 
       6 
Deckersbach et al 
(2017) 
       3 
Dobkin et al  
(2012) 
       1 
Goodkind et al 
(2016) 
       3 
Julian & Mohr 
(2006) 
       2 
Mohlman & 
Gorman (2005) 
       2 
Mohlman  
(2013) 
       2 
Moritz et al  
(2005) 
       3 
Vandborg et al 
(2016) 
       6 
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Appendix 1.6 Table of Executive Functioning scores reported for each test pre-CBT 
  Appendix E     
 Pooled Stroop Trails Verbal 
Fluency 
Card Sorting Digit Span 
What EF it 
tests 
 Inhibitory control, mental flexibility 
and selective attention 
Mental Flexibility  Concept formation, problem solving, 
explaining groups abstractly 
Working Memory 
Subtest  CW 
Incongru
ent 
Interference Stroop 
Effect 
B-A Switching 
(DKEFS) 
B  Perseverative 
error 
Percentage 
Completed 
Categories 
Free 
Sorting 
(DKEFS) 
Backwards Total 
Braga et al  
(2016) (Raw 
Score M (SE)) 
 39.6 
(1.60) 
1.23 (1.00)  56.2 
(6.89) 
      6.48 (0.31) 15.3 
(0.58) 
Carter et al., 
(2018)  z scores 
M(SD) 
0.15 (0.45)             
D’Alcante et al 
(2012) M (SE) 
   14.29 
(1.35) 
  89.66 
(9.55) 
 8.79 (2.47) 2.77 
(0.31) 
 Not reported 16.22 
(1.04) 
Deckersbach et 
al (2017) 
Scaled Scores 
M (SD) 
 10.41 
(2.00) 
9.71 (2.62)   10.23 
(2.08) 
    10.25 
(3.00) 
  
Dobkin et al  
(2012) Seconds 
M (SD) 
    82.15 
(71.20) 
        
Goodkind et al 
(2016) 
 Not 
reported 
     Not 
reported 
Not reported     
Julian & Mohr 
(2006) 
 Not 
reported 
     Not 
reported 
     
Mohlman & 
Gorman (2005) 
M (SD) 
WL 
Intact EF 
Improved EF 
ED 
 
 
 
138.38 (46.12) 
168.6 (10.45) 
117.00 (7.96) 
116.26 (11.27) 
Not 
reported 
      Not reported     
Mohlman  
(2013) t Scores 
M(SD) 
 50.42 
(12.47) 
    50.98 
(12.33) 
52.18 
(10.49) 
   50.39 (13.20)  
Moritz et al  
(2005): Non-
      81.16 
(43.86) 
76.47 
13.21 
(5.40) 
13.64 
22.65 
(13.86) 
19.01 
3.75 
(2.08) 
4.02 
 7.36 (2.73) 
 
7.21 (2.72) 
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respon; 
Resonders 
(35.89) (5.71) (12.28) (2.07) 
Vandborg et al 
(2016) M(SD): 
Recovered; 
Non-recovered 
  4.56 (9.32) 
1.36 (4.70) 
   73.44 
(39.53) 
64.78 
(27.36) 
39.19 
(14.04) 
43.30 
(12.51) 
 3.81 
(2.26) 
4.48 
(1.47) 
  14.63 
(3.93) 
14.39 
(3.73) 
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Appendix 2.1 Author Submission Guidelines for Cognitive and Behavioural Practice 
https://www.elsevier.com/journals/cognitive-and-behavioral-practice/1077-7229/guide-
for-authors 
Introduction  
Cognitive and Behavioral Practice is a quarterly international journal with the primary 
mission of clinical dissemination: to bridge the gap between published clinical research 
and the actual clinical practice of cognitive and behavioral therapies. Cognitive and 
Behavioral Practice publishes clinically rich accounts of innovative assessment and 
therapeutic procedures that are clearly grounded in evidence-based practice. The primary 
focus is on application and implementation of procedures. Accordingly, topics are selected 
to address current challenges facing practitioners, both in terms of technique, process, and 
the content of treatment. To meet this goal, articles may include rich descriptions of 
clinical interventions, examples of client-therapist dialog, embedded video clips readers 
can view on line, and/or significant case descriptions. This journal is for the practicing 
mental health clinician, instructors, and researchers with an interest in the clinical 
dissemination of their findings. Continuing education examinations are included in each 
issue. 
Types of contributions  
1. Teaching Clinical Strategies: These papers focus on educating the readership about 
how to conduct assessments and/or treatments with particular populations within an 
empirically supported framework. They must include case illustrations and 
preferably will include transcript material or video demonstrations. 
2. Teaching about other aspects of Clinical Practice: These papers might deal with 
supervision, legal and ethical issues, managed care issues, or giving legal 
testimony, for instance. There is no limit on the topics as long as they are relevant 
to clinical practice. 
3. Research Reports: These are papers that present clinically relevant research results. 
They may present new data on assessment, treatment or psychopathology. If they 
are short articles, the authors need only to point out briefly the clinical utility of the 
findings. Longer papers must include detailed case illustrations and, hopefully, 
transcript material to make the research findings clinically realistic and immediate. 
4. Treatment Development Reports: These papers might describe the theoretical 
foundation and iterative process used to develop a novel intervention or describe 
how an established treatment is adapted to a novel population or clinical setting. 
These papers might highlight issues of acceptability, feasibility, and initial 
outcomes, but competitive papers will highlight detailed description of the 
structure, strategies, and techniques the treatment employs. Case examples and/or 
video clips of interventions are encouraged that highlight how the treatment is 
implemented and how barriers/challenges are addressed. 
5. Special Series: These are collections of papers focusing on a special clinical topic. 
There is a Series Editor who develops the theme and then invites other clinicians 
and scientists to write topical papers that fit into the theme. 
6. Case Conferences: Like special series, case conferences are a collection of papers 
that focus upon a theme; in this instance, it is how to assess and treat a particular 
patient. The Case Conference Organizer writes up a detailed description of a case 
and selects four to eight Case Conference Respondents. The Case Conference 
Respondents write 6- to 20-page papers describing how they would assess and treat 
the patient. Also, the Respondents attend to special issues involved with treatment. 
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Typically, the Organizer writes up a summary of the similarities and differences 
among the approaches taken by the Respondents. 
7. Expert Clinical Commentaries: These are brief articles (solicited and unsolicited) in 
which experts in the field comment on the most up-to-date clinical topics, 
controversies, or discoveries within their expertise, and/or comment on an agenda 
for clinical research. These are roughly 3,000 words in length and are structured as 
a launching point for clinical practice and/or future clinical research. 
8. Clinical Reviews. These are regular length review articles that focus specifically on 
clinical strategy and existing evidence base for that strategy. 
Contact details  
Questions about the appropriateness of a manuscript for Cognitive and Behavioral Practice 
should be directed (prior to submission) to the Editorial Office, 
at bonnieb@bu.edu (Bonnie Brown, Editorial Assistant, Cognitive and Behavioral 
Practice, Center for Anxiety, Boston University, 648 Beacon Street, 6th Floor, Boston, MA 
02215). 
Submission checklist  
 
You can use this list to carry out a final check of your submission before you send it to the 
journal for review. Please check the relevant section in this Guide for Authors for more 
details. 
Ensure that the following items are present: 
One author has been designated as the corresponding author with contact details: 
• E-mail address 
• Full postal address 
All necessary files have been uploaded: 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided 
• Indicate clearly if color should be used for any figures in print 
Graphical Abstracts / Highlights files (where applicable) 
Supplemental files (where applicable) 
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources 
(including the Internet) 
• A competing interests statement is provided, even if the authors have no competing 
interests to declare 
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on journal requirements 
For further information, visit our Support Center. 
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Clinical trial results  
Randomized Clinical Trials: Use of CONSORT Reporting Standards 
Title of Manuscript 
The title of a manuscript should be accurate, fully explanatory, and preferably no longer 
than 12 words. The title should reflect the content and population(s) studied. If the paper 
reports a randomized clinical trial (RCT), this should be indicated in the title, and the 
CONSORT (Consolidated Standards of Reporting Trials) criteria must be used for 
reporting purposes. 
ABCT Journals require the registration of all clinical trials in a public trials registry. These 
registries set standards for the uniform reporting of the minimum registration data set as 
determined by the World Health Organization and the International Committee of Medical 
Journal Editors 
(http://www.clinicaltrials.gov, http://www.anzctr.org.au, http://www.umin.ac.jp/ctr, http://
www.isrctn.com, http://www.trialregister.nl/trialreg/index.asp/). Clinical trials are defined 
as any study that prospectively assigns human subjects to intervention or comparison 
groups to evaluate the cause-and-effect relationship between an intervention and an 
outcome. 
Manuscripts that report randomized clinical trials are required to include a flow diagram of 
the progress through the phases of the trial and a checklist that identifies where in the 
manuscript the various criteria are addressed (see http://www.consort-statement.org for a 
full description of reporting procedures). The checklist should be placed in an Appendix of 
the manuscript for review purposes. When a study is not fully consistent with the 
CONSORT statement, the limitation should be acknowledged and discussed in the text of 
the manuscript. ABCT journals do not view single case studies as being included among 
randomized clinical trials and are, therefore, exempt for these standards. 
For follow-up studies of previously published clinical trials, authors should submit a flow 
diagram of the progress through the phases of the trial and follow-up. The CONSORT 
checklist should be completed to the extent possible, especially for the Results and 
Discussion sections of the manuscript. 
ABCT Journals require the use of the CONSORT reporting standards (e.g., a checklist and 
flow diagram) for randomized clinical trials, consistent with the policy established by the 
International Committee of Medical Journal Editors' Uniform Requirements for Medical 
Journals. 
 
Article structure 
Subdivision - unnumbered sections  
Divide your article into clearly defined sections. Each subsection is given a brief heading. 
Each heading should appear on its own separate line. Subsections should be used as much 
as possible when cross-referencing text: refer to the subsection by heading as opposed to 
simply 'the text'. 
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If you are submitting original research, the structure of your paper should typically reflect 
the stages of the research process: 
Introduction 
Method 
Results 
Discussion 
However, as contributions to this journal take various forms (including empirical research, 
review articles, methodological papers, and case studies), authors are urged to organize 
their manuscripts in ways that make sense to their particular article type. 
A detailed description of all possible sections is shown below. 
Introduction  
State the objectives of the work and provide an adequate background, avoiding a detailed 
literature survey or a summary of the results. 
Methods  
Provide sufficient detail to allow the work to be reproduced. Methods already published 
should be indicated by a reference: only relevant modifications should be described. 
Results  
Results should be clear and concise. 
Discussion  
This should explore the significance of the results of the work, not repeat them. Avoid 
extensive citations and discussion of published literature. 
Conclusions  
The main conclusions of the study may be presented in a short Conclusions section, which 
may stand alone or form a subsection of a Discussion or Results and Discussion section. 
Glossary  
Please supply, as a separate list, the definitions of field-specific terms used in your article. 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae and 
equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in 
a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; 
Fig. A.1, etc. 
Essential title page information  
 
• Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Please clearly indicate the given name(s) and family 
name(s) of each author and check that all names are accurately spelled. You can add your 
name between parentheses in your own script behind the English transliteration. Present 
the authors' affiliation addresses (where the actual work was done) below the names. 
Indicate all affiliations with a lower-case superscript letter immediately after the author's 
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name and in front of the appropriate address. Provide the full postal address of each 
affiliation, including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. This responsibility includes answering 
any future queries about Methodology and Materials. Ensure that the e-mail address is 
given and that contact details are kept up to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the 
article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') 
may be indicated as a footnote to that author's name. The address at which the author 
actually did the work must be retained as the main, affiliation address. Superscript Arabic 
numerals are used for such footnotes. 
 
The journal uses a masked reviewing system for all submissions. The first page of the 
manuscript should omit the authors' names and affiliations but should include the title of 
the manuscript and the date it is submitted. Footnotes containing information pertaining to 
the authors' identity or affiliations should not be included in the manuscript, but may be 
provided after a manuscript is accepted. Every effort should be made to see that the 
manuscript itself contains no clues to the authors' identity. Authors should be careful to 
keep a copy of the manuscript to guard against loss. 
Cover Letter (including Authors' Names and Contact Information) 
The cover letter accompanying the manuscript submission must include all authors' names 
and affiliations to avoid potential conflicts of interest in the review process. Addresses and 
phone numbers, as well as email addresses and fax numbers, should be provided for all 
authors for possible use by the editorial office and later by the production department. 
Only original papers will be considered. Manuscripts are accepted for review with the 
understanding that the same work has not been and will not be published - nor is presently 
submitted - elsewhere, and that all persons listed as authors have given their approval for 
the submission of the paper; further, that any person cited as a source of personal 
communications has approved such citation. Written authorization may be required, at the 
Editors' discretion. Articles and any other material published in Cognitive and Behavioral 
Practice represent the opinions of the author(s) and should be construed as reflecting the 
opinions of the Editors, the Association, or the Publisher. 
Abstract  
 
A concise and factual abstract is required. The abstract should state briefly the purpose of 
the research, the principal results and major conclusions. An abstract is often presented 
separately from the article, so it must be able to stand alone. For this reason, References 
should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard 
or uncommon abbreviations should be avoided, but if essential they must be defined at 
their first mention in the abstract itself. 
Graphical abstract  
Although a graphical abstract is optional, its use is encouraged as it draws more attention 
to the online article. The graphical abstract should summarize the contents of the article in 
a concise, pictorial form designed to capture the attention of a wide readership. Graphical 
abstracts should be submitted as a separate file in the online submission system. Image 
size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or 
proportionally more. The image should be readable at a size of 5 × 13 cm using a regular 
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screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You 
can view Example Graphical Abstracts on our information site. 
Authors can make use of Elsevier's Illustration Services to ensure the best presentation of 
their images and in accordance with all technical requirements. 
Highlights  
Highlights are mandatory for this journal. They consist of a short collection of bullet points 
that convey the core findings of the article and should be submitted in a separate editable 
file in the online submission system. Please use 'Highlights' in the file name and include 3 
to 5 bullet points (maximum 85 characters, including spaces, per bullet point). You can 
view example Highlights on our information site. 
Keywords  
Immediately after the abstract, provide 3-5 keywords, using American spelling and 
avoiding general and plural terms and multiple concepts (avoid, for example "and", "of"). 
Be sparing with abbreviations: only abbreviations firmly established in the field may be 
eligible. These keywords will be used for indexing purposes. 
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed on the first 
page of the article. Such abbreviations that are unavoidable in the abstract must be defined 
at their first mention there, as well as in the footnote. Ensure consistency of abbreviations 
throughout the article. 
Acknowledgements  
For reasons of assisting with double-blind review, collate acknowledgements in a separate 
section on the title page beneath the author information. List here those individuals who 
provided help during the research (e.g., providing language help, writing assistance or 
proof reading the article, etc.). 
Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to funder's requirements: 
Funding: This work was supported by the National Institutes of Health [grant numbers 
xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and 
the United States Institutes of Peace [grant number aaaa]. 
It is not necessary to include detailed descriptions on the program or type of grants and 
awards. When funding is from a block grant or other resources available to a university, 
college, or other research institution, submit the name of the institute or organization that 
provided the funding. 
If no funding has been provided for the research, please include the following sentence: 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
Units  
Follow internationally accepted rules and conventions: use the international system of units 
(SI). If other units are mentioned, please give their equivalent in SI. 
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Math formulae  
Please submit math equations as editable text and not as images. Present simple formulae 
in line with normal text where possible and use the solidus (/) instead of a horizontal line 
for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. 
Powers of e are often more conveniently denoted by exp. Number consecutively any 
equations that have to be displayed separately from the text (if referred to explicitly in the 
text). 
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the article. 
Many word processors can build footnotes into the text, and this feature may be used. 
Otherwise, please indicate the position of footnotes in the text and list the footnotes 
themselves separately at the end of the article. Do not include footnotes in the Reference 
list. 
Artwork 
Electronic artwork  
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Embed the used fonts if the application provides that option.  
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, 
Symbol, or use fonts that look similar.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Size the illustrations close to the desired dimensions of the published version.  
• Submit each illustration as a separate file. 
A detailed guide on electronic artwork is available. 
You are urged to visit this site; some excerpts from the detailed information are given 
here. 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, 
Excel) then please supply 'as is' in the native document format.  
Regardless of the application used other than Microsoft Office, when your electronic 
artwork is finalized, please 'Save as' or convert the images to one of the following formats 
(note the resolution requirements for line drawings, halftones, and line/halftone 
combinations given below):  
EPS (or PDF): Vector drawings, embed all used fonts.  
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 
dpi.  
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum 
of 1000 dpi.  
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a 
minimum of 500 dpi. 
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these 
typically have a low number of pixels and limited set of colors;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
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Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or 
PDF), or MS Office files) and with the correct resolution. If, together with your accepted 
article, you submit usable color figures then Elsevier will ensure, at no additional charge, 
that these figures will appear in color online (e.g., ScienceDirect and other sites) regardless 
of whether or not these illustrations are reproduced in color in the printed version. For 
color reproduction in print, you will receive information regarding the costs from 
Elsevier after receipt of your accepted article. Please indicate your preference for color: 
in print or online only. Further information on the preparation of electronic artwork. 
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the 
figure. A caption should comprise a brief title (not on the figure itself) and a description of 
the illustration. Keep text in the illustrations themselves to a minimum but explain all 
symbols and abbreviations used. 
Text graphics  
Text graphics may be embedded in the text at the appropriate position. If you are working 
with LaTeX and have such features embedded in the text, these can be left. See further 
under Electronic artwork. 
Tables  
 
Please submit tables as editable text and not as images. Tables can be placed either next to 
the relevant text in the article, or on separate page(s) at the end. Number tables 
consecutively in accordance with their appearance in the text and place any table notes 
below the table body. Be sparing in the use of tables and ensure that the data presented in 
them do not duplicate results described elsewhere in the article. Please avoid using vertical 
rules and shading in table cells. 
References 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and 
vice versa). Any references cited in the abstract must be given in full. Unpublished results 
and personal communications are not recommended in the reference list, but may be 
mentioned in the text. If these references are included in the reference list they should 
follow the standard reference style of the journal and should include a substitution of the 
publication date with either 'Unpublished results' or 'Personal communication'. Citation of 
a reference as 'in press' implies that the item has been accepted for publication. 
Web references  
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed separately 
(e.g., after the reference list) under a different heading if desired, or can be included in the 
reference list. 
Data references  
This journal encourages you to cite underlying or relevant datasets in your manuscript by 
citing them in your text and including a data reference in your Reference List. Data 
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references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add [dataset] 
immediately before the reference so we can properly identify it as a data reference. The 
[dataset] identifier will not appear in your published article. 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and any 
citations in the text) to other articles in the same Special Issue. 
Reference management software  
Most Elsevier journals have their reference template available in many of the most popular 
reference management software products. These include all products that support Citation 
Style Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word 
processor plug-ins from these products, authors only need to select the appropriate journal 
template when preparing their article, after which citations and bibliographies will be 
automatically formatted in the journal's style. If no template is yet available for this 
journal, please follow the format of the sample references and citations as shown in this 
Guide. If you use reference management software, please ensure that you remove all field 
codes before submitting the electronic manuscript. More information on how to remove 
field codes. 
 
Users of Mendeley Desktop can easily install the reference style for this journal by clicking 
the following link: 
http://open.mendeley.com/use-citation-style/cognitive-and-behavioral-practice 
When preparing your manuscript, you will then be able to select this style using the 
Mendeley plug-ins for Microsoft Word or LibreOffice. 
Reference style  
Text: Citations in the text should follow the referencing style used by the American 
Psychological Association. You are referred to the Publication Manual of the American 
Psychological Association, Sixth Edition, ISBN 978-1-4338-0561-5, copies of which may 
be ordered online or APA Order Dept., P.O.B. 2710, Hyattsville, MD 20784, USA or 
APA, 3 Henrietta Street, London, WC3E 8LU, UK.  
List: references should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in the same 
year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of publication.  
Examples:  
Reference to a journal publication:  
Van der Geer, J., Hanraads, J. A. J., & Lupton, R. A. (2010). The art of writing a scientific 
article. Journal of Scientific Communications, 163, 51–59. 
https://doi.org/10.1016/j.Sc.2010.00372.  
Reference to a journal publication with an article number:  
Van der Geer, J., Hanraads, J. A. J., & Lupton, R. A. (2018). The art of writing a scientific 
article. Heliyon, 19, e00205. doi:10.1016/j.heliyon.2018.e00205. 
Reference to a book:  
Strunk, W., Jr., & White, E. B. (2000). The elements of style. (4th ed.). New York: 
Longman, (Chapter 4).  
Reference to a chapter in an edited book:  
Mettam, G. R., & Adams, L. B. (2009). How to prepare an electronic version of your 
article. In B. S. Jones, & R. Z. Smith (Eds.), Introduction to the electronic age (pp. 281–
304). New York: E-Publishing Inc. 
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Cancer Research UK. Cancer statistics reports for the UK. (2003). 
http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/ Accessed 13 
March 2003. 
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Association for Behavioural and Cognitive Therapies, New York, NY. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 82 
 
 
Appendix 2.2 ACT Group Protocol Outline (developed by Dr Clive Ferenbach and Dr 
David Grinter) 
 
Session Theme Summary of Content  
(Metaphors/Exercises) 
Homework 
1 Creative 
Hopelessness 
(a) Monster and the rope; (b) Zebras 
don't get ulcers; (c) ACT in a nutshell 
(a)'Just noticing' track on 
Mindfulness CD; (b) 
Adding to 'drop the rope' 
metaphor sheet 
 
2 Values (a) Passengers on a bus; (b) Verbal 
explanation of values; (c) Values and 
Goals as compass; (d) Miracle 
question; (e) Future birthday exercise 
(incorporating mindfulness) 
 
(a) Daily practice of 
mindfulness; (b) Add to 
values worksheet; (c) Take 
values based steps 
3 Noticing self, 
Present 
moment and 
Acceptance 
(a) Noticing self exercise and 
discussion of thinking vs. Noticing 
self; (b) Mountain metaphor; (c) 
Mindful eating exercise; (d) 
Acceptance of emotion mindfulness 
exercise' (e) Discussion of 
metacognitive attitudes towards 
emotion 
 
(a) Mindfulness exercises: 
'Noticing self' and 
'Everyday noticing; (b) 
Doing a task mindfully 
4 Defusion, 
Acceptance 
and 
Conceptualise
d Self 
(a) Recap thinking vs. Noticing self; 
(b) Radio metaphor; (c) Nursery 
rhyme exercise; (d) Lemon, lemon, 
lemon exercise; (e) Writing thoughts 
on cards and using defusion; (f) Fly 
fishing metaphor; (g) Thoughts not 
controlling actions; (h) 'Yes' and 'no' 
exercise 
 
(a) Mindfulness exercises: 
'Leaves on a stream' and 
'Calling out your struggle'; 
(b) Doing tasks mindfully 
and noticing 
thoughts/feelings 
5 Committed 
action  
(Obstacles 
and future 
planning) 
(a) General mindfulness exercise; (b) 
Recap passengers on a bus; (c) 
Flipchart exercise – obstacles and 
barriers to goals – solutions and 
compensatory strategies (SOC theory); 
(d) My action plan worksheet; (e) The 
travelling partners metaphor; (f) 
Acceptance of emotion mindfulness 
exercise; (g) My goals worksheet 
 
(a) Continued mindfulness 
CD practice; (b) Piece of 
committed action; (c) 
Continue daily 
mindfulness of tasks; (d) 
Further work on 'My goals' 
worksheet 
6 Summary (a) Noticing self mindfulness exercise; 
(b) 'My goals' worksheet continuation; 
(c) School of fish exercise; (d) Leaves 
on a stream exercise; (e) Discuss 
endings  
(a) Continuation of 
handouts  
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Appendix 2.3 ACT-OA Questionnaire (Original text size 14) (Developed by Dr Clive 
Ferenbach and Elizabeth Dewey) 
The Acceptance and Commitment Therapy measure of change  
 for Older Adults (ACT-OA)  
  
Please indicate the extent to which you agree or disagree with each of the following 
statements.  
  
1  2  3  4  5  6  
Strongly 
disagree  
Moderately   
disagree  
Slightly  
disagree  
Slightly 
agree  
Moderately 
agree  
Strongly  
agree  
  
Think of the last week or so when answering.  
  
  
  Strongly 
disagree  
Moderately   
disagree  
Slightly  
disagree  
Slightly 
agree  
Moderately 
agree  
Strongly  
agree  
1.  I was willing to experience 
unwanted or 
painful thoughts and 
feelings.  
  
1  2  3  4  5  6  
2.   I felt clear about what’s 
most important to me in 
life.   
  
1  2  3  4  5  6  
3.   I felt able to take a step 
back 
from difficult thoughts, 
and avoid getting too 
caught up in them  
  
1  2  3  4  5  6  
4.   I felt clear about how I 
could take steps to do 
more of what’s important 
to me.   
  
1  2  3  4  5  6  
5.   I didn’t let my own fears 
and doubts get in the way 
of taking action toward 
my goals.  
  
1  2  3  4  5  6  
  
Sum items for total score out of 30.  
 
 
 
 
 
 
 84 
 
 
Appendix 2.4 NHS Research and Development and REC Approval 
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Appendix 2.5 Amendments to Research Confirmation 
Amendment 1.  
 
Amendment 2.  
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Appendix 2.6 Participant Information Sheet 
                                                          
 
 
 
 
Mental Health & Wellbeing  
Administration Building  
Gartnavel Royal Hospital  
1055 Great Western Road  
Glasgow  
G12 0XH 
Participant Information Sheet 
Study Title: 
A Feasibility Study of Acceptance and Commitment Therapy with Older People. 
 
Who is conducting the research? 
This study is being carried out by: 
 Elizabeth Dewey, Trainee Clinical Psychologist and Principal Investigator (NHS Lanarkshire 
and University of Glasgow) 
 Dr Hamish McLeod, Chief Investigator (University of Glasgow) 
 Dr Clive Ferenbach, Field Supervisor (Senior Clinical Psychologist, NHS Lanarkshire) 
 
Invitation 
You are being invited to take part in a research study. Before you decide if you would like 
to take part it is important for you to understand why the research is being done and what 
it will involve. Please take time to read the following information carefully and discuss it 
with others if you wish. One of the research team will go through this information sheet 
with you and answer any questions that you have. This should take about 15 minutes. It is 
important that you take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
Acceptance and Commitment Therapy (ACT) is a psychological therapy that uses various 
strategies to help people to accept and respond more adaptively to troublesome thoughts 
and emotions. ACT also helps individuals to explore what is important in their life and helps 
people to behave in ways that are consistent with what they value. It can be an effective 
treatment for people with mental health difficulties. However, we need to learn about the 
suitability of and benefits of ACT for older people. This research will explore whether it is 
possible to deliver ACT groups to people over 65 and whether participants find it an 
acceptable approach. The research will mainly occur from October 2017 until July 2018, 
your connection to the study will last around 6 months. 
 
The study will be submitted as part of Elizabeth Dewey’s research portfolio as part of her 
requirements for completion of the Doctorate in Clinical Psychology at the University of 
Glasgow. 
 
Why have I been invited?  
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We are looking for participants who are over 65 years old, experiencing symptoms of 
emotional distress, and are going to take part in group therapy. We asked clinicians 
working in older adult services in Lanarkshire to identify people who meet these criteria 
and may be interested in taking part in this research. By taking part in the study, your 
routine care and Mental Health Act status will not be affected.  
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part in the research. Your access to the 
treatment group is not affected whether you agree to participate in the research. If you do 
decide to take part, you will be asked to sign a consent form. You are free to withdraw 
from the study at any time and without giving a reason. Regardless of whether you decided 
to participate or not, it will not affect any treatment you are currently receiving or any that 
you may need in the future. If you withdraw, the information we collected prior to this will 
be used in the study, but will be anonymised.  
 
What will happen to me if I take part?  
If you decide to take part and or would like more information, please tell the person who 
gave you this information sheet. They will pass your name to the researcher who will 
contact you to make an appointment. At this meeting, you can ask any questions that you 
have about the research. When you are sure that you would like to take part, the 
researcher will ask you to sign a consent form. You will attend the group treatment, which 
will take place once weekly and run for  six weeks. Each group session will last for 2 hours 
maximum with a break in the middle. Many of the questionnaires are already collected, so 
we will just ask for your consent to use these as part of the research data set. The 
additional tasks we will ask you to complete in addition to your participation in the group 
are: 
 Questionnaires before starting the group. These will take around 15 minutes to complete 
 One brief questionnaire after each group session, which will take around 5 minutes. 
 Outcome questionnaires at the end of the 5 sessions. These will take around 10 minutes to 
complete. 
 You will be posted these questionnaires3 months after the group finishes. This will take 
around 15 minutes to complete. 
 You will also be invited to attend an interview where you can share your experience of the 
group. If you do not complete all the sessions, we would still like to hear about your 
experience so we will contact you to invite you along to an interview and you can come 
along if you want too. This interview will last around 30 minutes and will be audio 
recorded. It will be anonymised so although we might use some of your quotes, your 
identity will be concealed and kept confidential.  
 
What are the disadvantages and risk of taking part? 
There is minimal risk of harm involved in taking part in this research project. There is a 
time burden associated with taking part in this research in that we ask you to complete 
some questionnaires that are additional to routine outcome monitoring. When filling out 
the questionnaires, difficult thoughts or feelings may arise when thinking of the answers. 
Similarly, you may experience some emotional distress when you are thinking about your 
life values and learning different ways to handle your difficult thoughts and feelings. 
These reactions are all within the scope of the kinds of experiences that people referred 
to psychology experience. If you do express feelings or thoughts of suicide or other 
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extreme forms of distress the researcher will inform a member of the clinical team so that 
you receive appropriate support and care. 
 
What are the possible benefits of taking part? 
There are no direct benefits. Some people find the experience of participating in the 
research interesting. Others have also reported that they enjoy contributing to the 
accumulation of new knowledge about ways to improve health care.  
 
Will my Psychiatrist and GP be notified? 
Yes, we will ask for your consent to inform your Psychiatrist (if applicable) and GP that you 
are taking part in the study. Your Psychiatrist will have no other involvement in the study. 
Clinical Psychologists will be running the groups.  
 
What happens when the research study ends? 
When the research study stops, you will no longer need to fill in questionnaires. 
 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. On all documents, an ID number will replace your name, and any 
personal information will be removed so that you cannot be identified from it. If you 
decide to take part in the post-treatment interview, this will be audio recorded. This 
recording will be transcribed, without your name being attached to it. The audio recording 
will be deleted to ensure privacy. Anonymous quotes from the interview may be used in 
the final report. 
 
What will happen to the results of the study? 
The results of the study will be written into a report and submitted to the University of 
Glasgow as part of Elizabeth Dewey’s requirements for the Doctorate in Clinical 
Psychology. It is possible that this report will also be published in an academic journal. A 
summary of this report will be distributed to the old age teams within NHS Lanarkshire. It is 
expected that this report will be completed by July 2018. 
 
Who is organizing and funding this research? 
The researched is organised via the University of Glasgow and is supported by the NHS. 
There is no commercial funding associated with this research. 
Who has reviewed the study? 
All research in the NHS is reviewed by an independent group of people called a Research 
Ethics Committee to protect your interests. The West of Scotland Ethics Committee has 
reviewed this study and favourable opinion has been given. 
 
If you have any further questions  
If you would like more information about the study and wish to speak with someone who 
is not closely linked to the study, please contact Dr Tom McMillan, University of Glasgow, 
email: thomas.mcmillan@glasgow.ac.uk, Tel no: 0141 2110354.  
 
If you have a complaint about any aspect of the study  
If you are unhappy about any aspect of the study and wish to make a complaint, please 
contact the researcher in the first instance. The normal NHS complaint procedure is also 
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available for you. The contact person for making a complaint in NHS Lanarkshire is: Laura 
Jack, NHS Lanarkshire Headquarters, Kirklands Hospital, Fallside Road, Bothwell, G71 8BB, 
Tel: 01698 858321, Email: laura.bryan@lanarkshire.scot.nhs.uk. 
 
Contact details 
If you would like further information, you can contact: 
Main Researcher (Trainee Clinical Psychologist): 
Elizabeth Dewey 
University of Glasgow 
Institute of Health and Wellbeing 
1055 Great Western Road 
Glasgow, G12 0XH 
e.dewey.1@research.gla.ac.uk 
 
Research Supervisors:  
Dr Clive Ferenbach      Dr Hamish McLeod           
Clinical Psychologist      University of Glasgow                               
Glendoe Building     Institute of Health and Wellbeing       
Coathill Hospital      1055 Great Western Road        
Coatbridge, ML5 4DN      Glasgow, G12 OXH 
Clive.ferenbach@nhs.net     Hamish.McLeod@glasgow.ac.uk 
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Appendix 2.7 Participant Consent Form  
                                                          
 
 
 
 
Mental Health & Wellbeing  
Administration Building  
Gartnavel Royal Hospital  
1055 Great Western Road  
Glasgow  
G12 0XH 
 
Participant Number:  
Name of researchers: Elizabeth Dewey, Dr Clive Ferenbach, Dr Hamish 
McLeod 
Title of Project: A Feasibility Study of the Process of Therapeutic Change 
Using Acceptance and Commitment Therapy (ACT) for Older People. 
Consent Form 
Please initial each box 
I confirm that I have read and understand the information sheet 
dated _________ for the above study and have had the 
opportunity to ask questions. 
 
 
I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason, without my 
medical care or legal rights being affected. 
 
 
I give consent to be contacted following the group to be invited to 
an interview, but understand that my participation in the interview 
is voluntary 
 
 
I understand that relevant sections of my medical notes and data 
collected during the study, may be looked at by individuals from 
University of Glasgow, from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records. 
 
 
 
I understand that if I decide to attend the interview, it will be audio 
recorded and quotations may be used in the final report. These 
quotations will be anonymous.  
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I understand that the information collected about me will be used 
to support other research in the future, and may be shared 
anonymously with other researchers. 
 
 
I agree to my Psychiatrist (if applicable) and GP being informed of 
my participation in the study. 
 
 
 
I agree to take part in the above study. 
 
 
 
 
 
 
-----------------------  -------------------------  ----------------- 
Name of Participant   Date    Signature  
 
-----------------------  -------------------------  ----------------- 
Name of Person taking consent  Date    Signature 
 
1 copy to the participant, 1 copy to the researcher, 1 original for the 
participant’s case-notes 
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Appendix 2.8 Interview Schedule 
Topic/Research Aim A: Acceptability to Older People 
I’m interested in how you experienced the group. Can you tell me about what it was like for 
you? 
 What was the group like? How did you find it? How was it for you? 
 What parts of the group did you like? What made this enjoyable? What did you 
enjoy? 
 What about the things you didn’t like? What made this dislikeable? What did you 
not enjoy? 
 What parts of the group were you most interested in? If people were to ask you 
about the group, what would you say? 
 Was there anything that surprised you? What was this? 
 What would you change about the group? Anything you would like more of? 
Anything you would like less of? 
 Was there anything the people who took the group said that you disagreed with? 
What were these? What was it about what they said that you disagreed with? 
 Was there anything in the group you found hard to follow? Anything you found a 
bit strange, or silly? Anything you didn’t understand? Tell me more about that.  
 
Topic/Research Aim B: Mechanisms of Change 
Now that you’ve been to the group, I’d like to find out about your life now. Can you tell me 
about the impact the group has had? 
 Have things changed for you since participating in the group?  Have there been any 
changes in how you  
 What do you think is the reason for these changes? Has there been anything about 
being in the group that would explain these? 
 What reasons have things stayed the same for you? Has there been anything about 
being in the group that would explain these? 
 What were the most important things about the group for you? Are they the 
reasons for things being better/worse? 
 
Topic/Research Aim C: Being part of a trial 
I’d now like to find out about how you found it being part of a research project. Can you tell 
me what it was like for you? 
 What were your initial thoughts about taking part in a research study? How did 
you make your decision to take part in the study?  
 How did you find the questionnaires? Were there any questions that stuck out for 
you or that you found difficult to answer? What were these? 
 
End of Interview: Any other information 
That’s all I have to ask, have you anything else you’d like to say, or anything we haven’t 
covered? 
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Appendix 2.9 Proposal  
Abstract  
Background: The majority of evidence for psychological interventions for depression, 
anxiety and psychosis, with older people (OP) has focused on Cognitive Behavioural 
Therapy (CBT), whereas it has been suggested that due to the chronicity and variety of 
mental health difficulties within this client group, Acceptance and Commitment Therapy 
(ACT) may be more suitable (Petkus & Wetherell, 2013). This is because ACT helps 
clients to relate differently to their difficulties and reconnect with values, rather than 
potentially unattainable symptom elimination.  
Aims: The acceptability and feasibility of an ACT based group intervention for OP; 
particularly in relation to whether values are an important part of the intervention for 
participants’ engagement with ACT.  
Methods: This study will take a mixed methods approach within a feasibility design. 
Participants who are over 65 and current inpatients on a functional inpatient ward will take 
part in a five-session ACT group and complete pre-, session-by-session, and post- 
intervention measures. They will also be invited to take part in a qualitative interview 
following intervention.  
Applications: The results will help inform whether participants find ACT an acceptable 
intervention, adding to its growing evidence base of ACT and OP. In addition, by 
measuring values clarity session-by-session it can consider whether this is an important 
part of the intervention for the client group.  
 
1. Introduction 
It’s estimated that by 2040, nearly one in four people in the UK will be over 65 (Age UK); 
previous studies have indicated that within this population there are a number of mental 
health difficulties (MacDonald, Raab & Storkey, 2001). Consequently, mental health 
services in the NHS need to adapt to this growing demographic and offer acceptable and 
beneficial interventions for OP led by research.  
 
Research for OP psychological treatment has focused on CBT, particularly for depression 
and anxiety, which has found to be more effective than waiting list control conditions, but 
as effective as other treatment conditions (Hofman et al, 2012 for a review of this 
literature). However, Petkus and Wetherell (2013) have argued that CBT has limited 
evidence for non-primary care OP clients and is suboptimal for anxiety. Many studies have 
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explored the difficulties that this client group share and have suggested that engaging in 
thought suppression, an attempt to stop thinking about a particular thought, is a large part 
of difficulties in this client group (Cukrowicz et al., 2011; Rosenthal et al., 2005).  
 
ACT is a psychological approach that aims to foster willingness to experience unwanted 
thoughts and feelings without necessarily changing their form (Harris, 2009). In this 
regard, ACT differs from other branches of CBT, which explicitly aim to change the 
content of thoughts, and reduce unwanted symptoms.  It also includes a strong behavioural 
component; aiming to help clients identify their deeply held ‘values’, and commit to 
pursuing activity congruent with these principles (Harris, 2009). Consequently, ACT aims 
not to decrease symptoms of distress but relate differently to them.  
  
It has been argued (Petkus & Wetherell, 2013) that ACT may be well suited for an OP 
population. This is partly due to its transdiagnostic applicability, relatively strong evidence 
base in chronic health conditions, and the intuitive appeal of an 'acceptance' based 
approach to some of the challenges of aging; particularly when cognitive 'challenge' 
appears less appropriate. However, the evidence base for ACT in OP is currently at a very 
early stage of development. This study aims to contribute to explore methods and measures 
to understand how ACT may be beneficial to OP. It has been suggested that values work 
may be most beneficial to mention earlier in intervention and to a greater extent when 
working with OP (Petkus & Wetherell, 2013) because they may be more likely to relate to 
values than emotional struggle. Petkus and Wetherell (2013) argue this may be a result of 
the number of significant life events that occur in later life, such as retirement or chronic 
illness, which could result in the person losing touch with their values. 
 
A range of measures have been used to measure the six processes of ACT (Acceptance; 
Contact with the Present Moment; Values; Committed Action; Self as Context; Cognitive 
Defusion) in addition to psychological flexibility, which these processes aim to target. 
Smout and colleagues (2014) have highlighted that there is not a measure that measures 
how clear an individual is about their values and whether their values are separate to what 
is expected from others. For example, someone may identify a value such as “being 
physically fit” because it is encouraged in their social system, but it may not be a personal 
value. As discussed before, it has been suggested that the identification and clarity of 
values may be more pertinent for this client group; however, there are no studies exploring 
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whether this is an important mechanism of change within this client group. Consequently, 
this study will measure this session-by-session with a new measure during the intervention; 
in addition to specifically asking participants about this process in interviews to consider 
whether values is an important mechanism of change, as Petkus and Wetherell (2013) 
suggest.  
 
Work is currently underway in NHS Lanarkshire on functional inpatient wards and 
community settings to develop group based ACT interventions and this study would aim to 
utilise these groups to explore how feasible and acceptable they are to deliver. This 
proposal is being constructed with reference to the MRC Complex Interventions Guidance 
(Craig et al, 2008), which describes the key elements of the feasibility/piloting process as: 
testing procedures; estimating recruitment/retention; and determining sample size. To 
establish this, it is recommended that using both qualitative and quantitative is needed to 
understand barriers.  
 
2. Aim 
To find out more about the suitability and acceptability of ACT for OP.  
Research Questions: 
Population: Is taking part in a research trial acceptable to this client group? What are the 
estimated rates of recruitment and retention of participants for future trials? This will be 
determined by information from attendance, attrition rates, and qualitative interview.  
Intervention: Are ACT groups acceptable to this client group? Does ACT need to be 
adapted? This will be determined by measuring attendance, attrition rates, and information 
from feedback forms, T-MIT and qualitative interview. 
Mechanisms for change: What are the possible/likely mechanisms for change during the 
intervention? This will be determined by information from qualitative interview, and 
outcome measures.  
Outcome Measures: Can appropriate measures be identified to explore the impact of an 
ACT intervention for OP and are they acceptable? This will be determined by 
completeness of questionnaires, satisfaction questionnaires, and qualitative interview.  
 
3. Plan of Investigation 
3.1 Participants 
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Participants will be recruited from older adult functional inpatient wards in NHS 
Lanarkshire, which are mixed bed mental health ward for patients over 65 who are 
experiencing varying presentations and severity of mental health difficulties and require 
support from a 24-hour service. Participants will also be recruited from patients who have 
been referred to psychology for a community ACT group.  
3.2 Inclusion and Exclusion Criteria  
Inclusion 
● Capacity to consent to research 
● Over 65 years old 
● Patient on older adult functional inpatient ward or within community services 
Exclusion 
● Known learning disability 
● Known cognitive impairment 
● Psychiatric symptoms that would exclude meaningful participation in the group, as 
identified by the clinical treating staff, for example active psychotic symptoms that 
would prevent the participant’s ability to attend/concentrate on the group  
3.3 Recruitment Procedures 
Participants will be recruited from older adult functional inpatient wards within NHS 
Lanarkshire; they will be patients who are already attending the ACT inpatient group. All 
patients who take part in the group have a pre-group assessment with the ward’s Clinical 
Psychologist, who is not part of the research team. Participants will also be recruited from 
community older people’s mental health teams. These participants will have been referred 
to psychology and been deemed suitable for a group intervention. During this pre-group 
assessment, an information sheet will be provided to the patient and they will be asked 
whether a researcher can contact them after 24 hours to discuss the project. Subsequently, 
if the patient agrees for the researcher to contact them, an appointment will be arranged to 
provide further information and ask whether the patient wishes to participate in the study.  
3.4 Measures 
The Brief Experiential Avoidance Questionnaire (Gamez et al, 2014) is a 15-item measure 
of experiential avoidance. The authors reported this measure to have a mean of α=0.86. It 
has not been previously used in studies with OP. 
 
The Valuing Questionnaire (VQ) (Smout et al., 2014) is a ten-item measure of values. The 
authors reported this measure to have a mean of α=0.95 for successful valued living and 
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α=0.93 for disrupted valued living.  It has not previously been used in an older adult 
population.  
 
The Cognitive Fusion Questionnaire (CFQ) (Gillanders et al., 2014) is a seven-item 
measure of cognitive fusion. The authors reported this measure to have a mean of α=0.90. 
This measure has been used with an older adult population (Scott et al., 2016) with an 
internal consistency of α=0.74.  
 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) is a 14-
item measure of anxiety and depression. A study that reviewed 747 papers that used the 
HADS (Bjelland et al., 2002) found that the mean of the anxiety subscale was α=0.83 and 
depression subscale was α=0.82.  
 
A session-by-session measure created by the authors (The Acceptance and Commitment 
Therapy measure of change for Older Adults (ACT-OA)), with five items, will be used to 
measure clarity of values, clarity of planned action, engagement in valued living and 
willingness to experience difficult thoughts and feelings. This is to clarify whether values 
are an important aspect of the ACT intervention for OP and whether each of these four 
areas influences another during intervention.  
 
The Therapeutic-Metaphors Interpretation Test (T-MIT) (Hains, 2013) is a six-item 
measure of abstract thinking. Research suggests that some OP have executive deficits as a 
result of normal ageing (Mohlman & Gorman, 2005), which includes abstract thinking. 
Consequently, this measure aims to explore whether participants have an understanding of 
the therapeutic metaphors, which will help to explore whether the session content needs to 
be adapted. 
3.5 Design 
This is a feasibility study and will be a mixed methods design, using quantitative and 
qualitative methods, as recommended by the Medical Research Council guidance for 
complex interventions (Moore et al, 2015). In relation to the qualitative design, as the 
research question is experiential, Braun and Clarke (2013) recommend conducting 
interviews with a small (6-10)/moderate (10-20) sample size and using thematic analysis as 
this qualitative method aims to identify patterns across all participants, which fits with the 
research objectives. 
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3.6 Research Procedures 
● Acceptance and Commitment Therapy Protocol 
ACT has been more described as a general approach rather than being manualised (Petkus 
& Wetherell 2013). Therefore, the protocol has been developed by two NHS Lanarkshire 
Clinical Psychologists and is based on the outline of sessions in ACT Made Simple (Harris, 
2009). This protocol has been rolled out twice and following this has created a protocol of 
6 sessions with each session concentrating on a particular part of the hexaflex.  
● Training 
The group is delivered as part of standard care and is facilitated by Clinical Psychologists 
working with Psychological Therapies for OP in NHS Lanarkshire, who works four 
sessions on the ward. The Clinical Psychologists have attended ACT training and have a 
number of years experience delivering ACT individually and in groups.  
 Data Collection 
Questionnaires will be given to participants pre- and post- intervention and the session-by-
session measure will be used every group session. Following the group, participants will be 
invited to attend a semi-structured interview, conducted by the Trainee Clinical 
Psychologist, to discuss particular aspects of the group. All participants will also be 
contacted by post 12 weeks after the end of the intervention with the measures.  
 
Interviews will then be transcribed and following this the recording will be deleted. All 
confidential information will be removed and each transcription will be identifiable by 
number.   
3.7 Data Analysis 
Quantitative Analysis 
Within subjects t-tests, or the non-parametric equivalent, will be used to explore group 
level change pre/post treatment, which, alongside interviews, will aid in looking at the 
possible mechanisms for change.  
 
Descriptive analysis will be used to explore the T-MIT data, to explore potential 
adaptations needing to be considered in relation to abstract thinking and ACT.  
 
Qualitative Analysis 
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Thematic analysis, using Braun and Clarke’s (2014) guidelines, of qualitative interviews 
will be used to explore the research objectives of adaptations relating to ACT and whether 
the outcome measures are acceptable to participants.  
 
3.8 Justification of Sample Size 
As this is a feasibility study and therefore exploratory, a power calculation does not need to 
be completed and worked to.  However, one of the outcomes from this study is to generate 
post-hoc power calculations from change scores on the outcome variables within the group 
to guide future studies. It has been estimated from previous groups that 6-8 participants 
will be in each group with two groups running (estimated total eligible pool = 16). As 
outlined above, for this study, Braun and Clarke (2013) recommend a small (8-
10)/moderate (10-20) sample size. All participants will be invited for interview and 
saturation will be established during analysis; however, based on previous research, it 
would be expected that saturation would be reached by 12 interviews (Baker & Edwards, 
2012).   
3.9 Settings and Equipment 
The groups will take place on a mental health ward for OP, as described above, or within a 
community setting.  
Equipment Source 
Group  
Measures (BEAQ; CFQ; HADS; VQ; T-MIT; 
ACT-OA) 
Information Packs and Consent Forms 
Available online (printing costs) 
 
Printing costs 
Interviews  
Audio Recorder 
Laptop and Foot Pedal 
Loan from University 
Loan from University 
4. Health and Safety Issues 
4.1 Researcher Safety Issues 
The groups will be delivered on hospital grounds or community health centres within 
working hours, and therefore there will be a number of staff available. Procedures for panic 
alarms will be consulted prior to starting the groups, which is routine practice to know for 
each place of work, and the facilitators also have panic alarms.   
4.2 Participant Safety Issues 
As the setting is a functional ward, participants may become distressed during the group 
sessions. This has occasionally been the case with previous groups; however, as ward staff 
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will be aware of how patients respond, this information will be sought prior to 
commencing the group. This will be equally considered within the community groups. Any 
patients who become highly distressed during the group will be sensitively engaged by the 
facilitators and followed up after the session. This will be recorded in their notes and it will 
be discussed with the patient whether they feel able to continue in the session and/or with 
the research.  
4.3 Ethical Issues 
Ethics submission will be made to NHS REC. Management approval from NHS 
Lanarkshire R&D will be sought following ethical approval. All data will be stored in 
locked filing cabinets or password protected databases after anonymisation. Recording of 
the interviews will be destroyed following transcription. All transcripts will be anonymised 
using the Find and Replace function in word: e.g. Name replaced with {Person 1, 2, 3 etc.} 
to minimise direct and indirect threats to identification. Participants will also be informed 
that quotations will be used in the presentation of results.  Within this patient group there 
may be difficulties around individual’s capacity to consent as some patients on the ward 
may be detained under the Mental Health Act 1983; however, they may still be able to 
consent for research. The following conditions will be considered when assessing informed 
consent in potential participants (Van Staden & Kruger, 2002), their mental disorder 
should not prevent a patient from: 
1. Understanding what they consent to 
2. Choosing decisively for/against the intervention 
3. Communicating their consent  
4. Accepting the need for a medical intervention 
5. Financial Issues 
Costs would be based around paperwork for the study, including handouts and 
questionnaires. A recorder, laptop and pedal would be required for the researcher to 
transcribe the interviews, which may be available to borrow from the university.  
 
6. Timetable 
Date Action 
30th January 2017 MRP Proposal Submission 
15th May 2017 Submit Final MRP Proposal and Paperwork to University 
August 2017 Submit Ethics Application 
October-December 2017 First and second cycle of ACT group delivery 
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(delivery of 5 sessions and data collection, including post-
intervention interviews) 
January-April 2017 Data analysis and write up 
 
7. Practical Applications 
This study aims to explore the acceptability and feasibility of ACT based groups on older 
adult wards and in community settings. Consequently, it has practical applications because 
it can help inform the service whether the participants find ACT helpful as measured by 
the outcome measures and qualitative feedback. In addition, the results of this study can 
contribute to the small literature base of ACT and OP. Also, by developing a new measure 
looking at values and using it in this research project we are able to trial this outcome 
measure.  
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